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ABSTRACT 
KATHARINE ROSE TYSON: A family of tick (Ixodes scapularis) salivary proteins that 
inhibit complement 
(Under the direction of Aravinda de Silva) 
 
 Ixodes scapularis, the blacklegged tick, is an ectoparasitic bloodsucking arthropod 
that transmits multiple pathogens, including Borrelia burgdorferi, the agent of Lyme disease.  
I. scapularis ticks secrete numerous salivary anti-hemostatic, anti-inflammatory, and 
immunosuppressive compounds into the host to inhibit host responses that could interfere 
with feeding.  I. scapularis anti-complement protein (Isac) specifically inhibits the alternative 
complement pathway by destabilizing the C3 convertase.  Here, we report on the 
identification of several tick proteins that are paralogues of Isac and members of the Isac-like 
protein (ILP) family, which contains at least 49 unique proteins.  In this work we have 
characterized the biochemical and functional activities of multiple ILPs, their mechanisms of 
complement inhibition, and their roles in facilitating tick feeding. 
 We expressed recombinant ILPs (rILPs) that possessed several N- and O-linked 
glycans and inhibited the alternative complement pathway by destabilizing C3 convertases, 
similar to Isac.  rILPs specifically bound properdin, a positive regulator of the alternative 
complement pathway, causing its removal from C3 convertases and accelerating decay of the 
convertases.  This mechanism of complement regulation is distinct from any characterized 
negative regulators of the alternative complement pathway, which mediate decay 
acceleration by interacting with Bb or C3b. 
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 As I. scapularis ticks likely co-express multiple ILPs during tick feeding, we 
evaluated various properties of individual ILPs that possibly justify their co-expression.  
When multiple rILPs were added together, no synergistic effects were observed, indicating 
the proteins acted individually.  Individual rILPs also inhibited the alternative complement 
pathway from different animal hosts comparably, indicating rILPs did not display host 
specificity.  We believe that individual I. scapularis ILPs likely display antigenic variation, 
justifying their co-expression during tick feeding.  
 Expression of the ILP gene family is likely essential for successful tick feeding as 
ILPs suppress host innate immune responses.  RNAi mediated gene silencing of the ILP 
genes and the generation of antibodies against rILPs in immunized mice had no effect on 
successful I. scapularis nymphal tick feeding.  However, RNAi may have not revealed a 
phenotype because of redundancy in the ILP genes. Similarly, ILP specific antibodies may 
have showed no phenotype because of antigenic variation between different ILPs and 
redundancy in ILP functions.   
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CHAPTER 1 
 
Background and Significance 
 
1.1 Introduction
Ticks are obligate parasitic blood-sucking arthropods that feed on a wide variety of 
vertebrate hosts including mammals, birds, reptiles and some amphibians (22, 138).  Ticks 
are distributed on virtually every continent, excluding Antarctica, where they are persistent 
pests of livestock and wildlife (63, 137).  Tick infestations of livestock can cause severe toxic 
conditions, including tick paralysis, toxicoses, allergic reactions, and severe blood loss, 
which can lead to major economic losses in several countries.  In addition to causing several 
severe pathogenic conditions, ticks are also important vectors of numerous viral, bacterial, 
and protozoan pathogens that cause various diseases in animals and humans including 
babesiosis, ehrlichiosis, tularemia, Rocky Mountain spotted fever, tick-borne encephalitis, 
Crimean-Congo hemorrhagic fever, and Lyme disease, the most prevalent vector-borne 
disease in the United States and Europe (22, 137, 138).   
Approximately 850 species of ticks exist worldwide, which are separated into two 
major families, the Ixodidae (hard ticks) and the Argasidae (soft ticks) (6, 22, 42, 137).  A 
third family exists, the Nuttaliellidae, containing only a single species.  The life cycle of ticks 
consists of three developmental stages (instars), the larva, nymph, and adult (138).  Larval 
ticks have 3 pairs of legs like insects, while nymphal and adult ticks possess 4 pairs of legs, 
resembling arachnids, which are comprised of ticks, mites, spiders, and scorpions (93, 137, 
138).  Tick mouthparts consist of three main appendages: the chelicerae, which are toothed 
organs used for cutting, ripping, and tearing skin; the palps, which are sensory organs used 
for host attachment; and the hypostome, which is the barbed mouthpart inserted into the skin 
during feeding (Fig 1.1A) (137, 138).  Ixodidae, or hard ticks, possess a tough, sclerotized 
plate, the scutum, on their dorsal body surface, which acts as an attachment site for many 
vital muscle groups (Fig 1.1B) (42, 137, 138).  Argasidae, or soft ticks, lack a scutum but 
possess a tough leathery cuticle that is highly folded, allowing ample growth during feeding 
(Fig 1.1B).  Due to their feeding and molting characteristics, ixodid and argasid ticks both 
exhibit long life spans, lasting several years.  Even though they share many common 
features, drastic differences exist between argasid and ixodid ticks. 
Argasidae 
 Argasid ticks can be subdivided into four main genera, Argas, Carios, Ornithodoros, 
and Otobius, where Argas, Ornithodoros, and Otobius ticks are important medical and 
veterinary pathogen transmission vectors (22, 63).  As mentioned previously, argasid ticks 
lack a scutum, containing only a tough, leathery cuticle with many folds, giving rise to the 
term “soft ticks” (42, 137, 138).   The mouthparts of argasid nymphs and adults are found at 
the anterior end of the body, but are covered by the body and cannot be seen from the dorsal 
view (Fig 1.1B).  Argasid ticks are typically found in environments very close to their hosts, 
such as bird nests, bat caves, burrows and dens of various animals, or dilapidated huts and 
cabins of humans (99, 138).  When ready to feed, argasid ticks attach to hosts by cutting into 
the skin with their chelicerae and inserting their barbed hypostome (6, 42, 93, 99, 137, 138).  
Once attached, they begin to secrete saliva into the host and suck blood from the host.  
Argasids only feed for short periods of time, usually several minutes.  As they feed, their 
 2
highly folded body cuticle stretches to accommodate the incoming host blood meal, which is 
approximately 5-10 times their body weight.  In order to maximize blood consumption, the 
tick concentrates the blood as it feeds by secreting a colorless fluid consisting of water and 
salts extracted from the blood from pores in the body.  
Argasid ticks typically have a multi-host life-cycle (22, 42, 93, 99, 137, 138).  Larvae 
emerge from eggs and attach to a host, feed to repletion, drop off, and molt into nymphs.  
Nymphs then feed on the same or a different host, drop off, and molt.  Nymphs usually feed 
several times on multiple hosts and undergo 3 to 5 molts before becoming adults.  Once 
adults, females may mate before or after feeding away from a host.  After feeding to 
repletion, adult females drop off the host and lay several hundreds of eggs.  Argasid females, 
like nymphs, are also capable of feeding numerous times and laying multiple batches of eggs 
several times during their lifetime.    
Ixodidae  
 Ixodid ticks, which account for approximately 80% of all tick species worldwide, are 
subdivided into seven genera including Amblyomma, Dermacentor, Haemaphysalis, 
Hyalomma, Ixodes, Rhipicephalus, and Boophilus (63).  Ixodid tick species within each of 
the seven genera are important medical or veterinary pathogen transmission vectors (22).  
Ixodid ticks possess a scutum, or a tough, sclerotized plate, on their dorsal surface giving 
them the name “hard ticks” (6, 42, 137, 138)  In adult males, the scutum covers the entire 
dorsal body surface, while it only covers a portion of the dorsal body surface in nymphs and 
adult females.  As ixodid ticks are sensitive to environment humidity and temperature 
conditions, most of the body in nymphs and adult females, excluding the scutum, is covered 
by a waxy, tough, dense cuticle that prevents desiccation (138).  The mouthparts of ixodid 
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ticks are very similar to argasid ticks and located at the anterior end of the body.  However, 
unlike argasids, the body does not cover the mouthparts in ixodids and can be readily seen 
from the dorsal view (Fig 1.1B) (6, 42, 137, 138).  Ixodid ticks are usually found in brushy, 
wooded, or weedy areas populated by medium or large sized mammals (42, 138). 
 The life-cycle and feeding characteristics of ixodid ticks are different from argasid 
ticks.  Ixodid ticks display a two- or three-host life-cycle, as opposed to argasid ticks, which 
display a multi-host life-cycle (6, 42, 93, 137, 138).  Larvae emerge from eggs and attach to 
small animals for their first blood meal.  After feeding for several days to repletion, larvae 
drop off the host and molt into nymphs.  In some ixodid species, larvae remain on the host 
after feeding and molt into nymphs.  Nymphs then either seek a new host to feed or feed 
from the same host if the larvae remained on the host after the initial feeding.  After the 
second feeding, the nymphs drop off the host and molt into either female or male adults.  
Adult ixodid ticks attach to a new host and begin feeding, and mating typically occurs during 
feeding.  After feeding to repletion, the mated female adult drops off the host, lay thousands 
of eggs, and dies.  When larvae emerge from the eggs, the cycle repeats itself.  Unlike 
argasid ticks, ixodid ticks only ingest three blood meals and molt three times in their lifetime.  
Since ixodid ticks do not undergo multiple nymphal molts like argasid ticks, the ixodid life-
cycle is typically shorter, usually 1-2 years depending on environmental humidity and 
temperature conditions, than the argasid tick life-cycle.            
Feeding Characteristics of Ixodid Ticks 
 Ixodid ticks exhibit unique feeding characteristics, distinguishing them from argasid 
ticks and other blood feeding arthropods including flies, fleas, mosquitoes, and mites.  Unlike 
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most blood sucking arthropods, ixodid ticks feed for several days on a single host, consuming 
large quantities of blood.   
The majority of ixodid tick species find suitable hosts using a strategy termed 
“questing” (6, 22, 42, 137, 138), which consists of climbing blades of grass, weeds, or bushes 
and waiting for a host to brush against them.  While questing, ticks remain hydrated by 
moving from their perch to the humid environment of the leafy ground cover and secreting a 
hygroscopic, salty saliva solution onto their hypostomes that adsorbs water from the 
surrounding atmosphere.  Once rehydrated, the ticks climb back up the vegetation and 
continue waiting for a host.  Ixodid and argasid ticks sense approaching hosts by several 
factors including shadows, vibrations, and odors.  Ticks are especially attracted to carbon 
dioxide, which is found in host breath, and ammonia, which is found in host urine.  When 
they finally sense a host, ticks stretch out their forelegs and cling to the hair or clothing of the 
host.  Some species of ixodid ticks, in particular species of Hyalomma, actively hunt their 
hosts (22, 138).  These ixodid ticks bury themselves in sand or dirt, preventing desiccation.  
When they sense a nearby host, they emerge from the ground and run towards the host. 
Upon finding an appropriate host, ticks use the sensory organs in their palps to locate 
an attachment site (137, 138).  Once an attachment site is found, the chelicerae of the tick 
begin slicing into the skin in an outward motion, creating a small hole (6, 42, 99, 137, 138).  
The tick then inserts the barbed hypostome into the hole and secretes a proteinaceous cement 
compound.  The cement covers the hypostome and host skin, acting as an adhesive to anchor 
the hypostome in place.  Since argasid ticks only feed for a few hours rather than several 
days, they do not secrete any cement upon attachment.  In ixodid ticks, the process of 
attachment may take hours to days, but once firmly attached, the ticks are hard to remove. 
 5
After the tick is firmly cemented in place, blood feeding begins from a pool created 
by tissue and blood vessel damage during attachment (6, 93, 99, 138).  For the first few days, 
feeding proceeds slowly as new cuticle is synthesized to allow expansion of the ixodid tick 
with the incoming blood meal.  Once the new cuticle has been synthesized, feeding proceeds 
rapidly and the tick may increase its weight 10 (larvae and nymphs) to 100 (adult mated 
females) times its prefed weight (93, 99, 137, 138).  Since adult ixodid males are covered by 
the rigid scutum and cannot expand easily, they usually do not ingest large amounts of blood 
when feeding.  Feeding is discontinuous, characterized by periods of blood sucking 
alternating with periods of tick salivation (99, 138).  In order to maximize blood 
consumption, portions of ixodid tick salivary glands function as water secreting 
compartments that remove excess water and salts to concentrate the blood meal (93, 99, 137, 
138).  When the tick is replete, it will drop off the host and either molt (larvae or nymphs) or 
lay eggs (adult mated females).  
 
1.2 Host Responses to Tick Feeding     
 Ticks acquire a meal by sucking blood from a pool created during attachment, when 
the mouthparts cut into the skin, lacerating numerous small blood vessels and causing tissue 
destruction at the feeding site (93, 99, 145).  The host is normally capable of detecting and 
repairing wounds through the processes of hemostasis and inflammation.  Hemostatic 
responses prevent blood loss, potentially making the acquisition of a blood meal difficult for 
the tick (93, 120, 133, 145).  Inflammation results in redness, swelling, and irritation at the 
feeding site, allowing the host to sense the presence of the tick, which potentially leads to 
host grooming and tick removal (99, 120, 133).  In order to counteract the hemostatic and 
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inflammatory responses of the host, ticks produce multiple anti-hemostatic and anti-
inflammatory mediators that are secreted into the host through the saliva during feeding.  
In addition to hemostatic and inflammatory responses, other host immune responses 
may also be triggered during tick attachment and feeding.  Host immune responses likely 
mediate recognition of multiple tick antigens, eventually resulting in rejection of the feeding 
tick (120).  Tick rejection is normally characterized by a reduction in fed tick weights, altered 
feeding times, a reduction in the viability and number of ova produced, impaired molting, 
and death of the feeding tick (120, 133, 162).  In addition to secreting anti-hemostatic and 
anti-inflammatory mediators, ticks also secrete immunosuppressive molecules in their saliva 
to prevent host immune recognition and rejection (93, 99, 120, 133).   
                 
1.3 Anti-Hemostatic Tick Salivary Components 
 Hemostasis, a host response generated during tissue injury, prevents blood loss from 
damaged tissues through platelet aggregation, vasoconstriction, and blood coagulation (7, 16, 
93, 120, 133, 145).  In order to obtain a complete blood meal successfully by avoiding host 
hemostatic responses, many blood sucking arthropods, including mosquitoes, flies, lice, fleas, 
mites, and ticks, secret salivary anti-hemostatic components into the host during feeding (7, 
16, 17, 41, 120, 141).  Argasid, and in particular ixodid ticks, which feed on a host for 
periods of several days, secrete a wide variety of anti-hemostatic molecules including platelet 
aggregation inhibitors, vasodilators, and anti-coagulants, which all aid the tick in overcoming 
host hemostasis.   
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Platelet Aggregation Inhibitors 
Tissue damage leads to the exposure of various agonists, including adenosine 
diphosphate (ADP) and collagen, which cause platelet aggregation.  In order to prevent 
platelet aggregation, many blood feeding arthropods secrete salivary apyrases, which are 
enzymes that hydrolyze adenosine triphosphate (ATP) and ADP into adenosine 
monophosphate (AMP) and inorganic phosphate.  Eliminating ADP potentially prevents 
activation and aggregation of platelets (16, 93, 99, 133).  Apyrase activity has been identified 
in the saliva or SGE of the soft ticks Ornithodoros savignyi, Ornithodoros moubata, and 
Argas monolakensis, as well as the hard tick, Ixodes scapularis (Table 1.1) (88, 89, 93, 99, 
118, 120, 121).  O. moubata also expresses moubatin and tick adhesion inhibitor (TAI), 
salivary gland proteins that specifically inhibit collagen induced platelet aggregation or 
adhesion, respectively (Table 1.1) (67, 70, 156).   
Once platelets are activated by various agonists, they express glycoprotein IIbIIIa 
(GPIIbIIIa) on their surfaces.  This integrin binds fibrinogen or von Willebrand’s factor, 
resulting in platelet cross-linking and aggregation (7, 93, 145).  In addition to apyrases, ticks 
have also developed salivary components that block GPIIbIIIa, preventing fibrinogen binding 
and platelet aggregation.  Dermacentor variabilis, O. moubata, O. savignyi, and A. 
monolakensis, produce salivary gland proteins that bind GPIIbIIIa, inhibiting fibrinogen 
binding or displacing bound fibrinogen from the receptor (Table 1.1) (66, 88, 91, 92, 155).  
These activities either prevent platelet aggregation or cause aggregated platelets to 
disaggregate.  I. scapularis saliva is also capable of causing platelet disaggregation through 
the proteolysis of fibrinogen (30).  The presence of multiple platelet aggregation inhibitors in 
a variety of ticks indicates the necessity to inhibit this host response during feeding. 
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Vasodilators 
 Many blood feeding arthropods employ a variety of strategies to promote 
vasodilation, which counteracts vasoconstriction induced by platelet aggregation and 
increases the rate of blood flow to the feeding site (16).  In order to maintain blood flow 
during their extended feeding periods, ixodid ticks produce and secret numerous salivary 
prostaglandins.  As argasid ticks feed for much shorter periods, prostaglandins have not been 
detected in their saliva.  Ixodid salivary prostaglandins are lipid molecules that promote 
smooth muscle relaxation, causing vasodilation (7, 12).  Prostaglandin E2 has been identified 
in the saliva of many ixodid ticks including, Boophilus microplus, Haemaphysalis 
longicornis, Amblyomma americanum, Ixodes holocyclus, and I. scapularis (Table 1.1) (3, 
13, 23, 57, 119, 130).  In addition, I. scapularis also produces prostaglandin I2, while A. 
americanum produces prostaglandin F2 (3, 119, 122) .  Besides their primary functions in 
vasodilation, prostaglandins also display immunosuppressive effects and prevent platelet 
aggregation (12, 130). 
 Tissue damage and platelet activation and aggregation lead to elevated levels of Ca2+, 
which potentially triggers vasoconstriction (7).  Several ixodid tick species secrete salivary 
calreticulins, which bind Ca2+, potentially preventing vasoconstriction (Table 1.1) (29, 37, 
59, 128, 163).  Similar to prostaglandins, calreticulins may also display anticoagulant and 
immunosuppressive functions in addition to vasodilatory activities as Ca2+ is required for a 
variety of host cell responses (14, 16, 59).            
Anticoagulants 
 Blood coagulation is initiated through two different pathways, either the intrinsic or 
the extrinsic pathway (16, 93, 145).  Both pathways converge at the step of factor X (FX) 
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activation into FXa.  FXa activates prothrombin into thrombin, which then cleaves fibrinogen 
into fibrin.  Fibrin then polymerizes, ultimately resulting in clot formation, which prevents 
blood loss from damaged tissues.  Numerous blood feeding arthropods, including argasid and 
ixodid ticks, secrete anticoagulants into the host during feeding, inhibiting blood coagulation.  
Interestingly, single ixodid tick species typically express several anticoagulants, as opposed 
to argasid ticks, likely because of their prolonged feeding times.  Most tick salivary 
anticoagulants inhibit either FXa or thrombin.  Several species of Ixodes, Hyalomma, 
Rhipicephalus and Ornithodoros ticks secrete various salivary proteins that directly bind 
FXa, preventing it from activating prothrombin (Table 1.1) (5, 39, 55, 64, 86, 100, 101, 157).  
Additionally, species of Ixodes, Boophilus, Haemaphysalis, Hyalomma, Amblyomma, and 
Ornithodoros also secrete salivary proteins that directly bind thrombin, preventing it from 
cleaving fibrinogen (Table 1.1) (5, 19, 49, 50, 54, 58, 72, 88, 90, 97, 103, 148, 165, 166).  
Ticks also produce salivary components that inhibit blood coagulation prior to the activation 
of FX.  I. scapularis, Dermacentor  andersoni, and O. savignyi secrete salivary proteins that 
inhibit the extrinsic, or tissue factor pathway, and H. longicornis secretes an intrinsic 
pathway inhibitor (24, 31, 32, 43, 69).  Presumably, inhibition of blood coagulation by 
various secreted salivary components is essential for successful argasid or ixodid tick 
feeding.    
   
1.4 Anti-Inflammatory Tick Salivary Components  
 Tissue damage, platelet activation and aggregation, and activation of blood 
coagulation all trigger the induction of inflammation, a host response resulting in pain, itch, 
redness, and irritation at the site of tissue damage (120).  Inflammation can lead to host 
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grooming, resulting in removal of a feeding tick (145).  In order to obtain a blood meal 
without premature host removal during their extended feeding periods, ixodid ticks secrete an 
array of anti-inflammatory proteins including histamine-binding proteins, kininases, and 
anaphylatoxin inhibitors.  
Histamine-binding proteins  
 Histamine and serotonin are essential mediators of inflammation that cause itching 
sensations, edema, and erythema by increasing vascular permeability (99, 133, 145).  As 
ixodid ticks feed for several days, they have developed histamine-binding proteins (HBPs) to 
inhibit the activities of histamine and serotonin and prevent inflammation during feeding.  
Rhipicephalus sanguineus SGE inhibit the activity of histamine, and Rhipicephalus 
appendiculatus was found to express three salivary HBPs (18, 107).  Homologues of these 
proteins have been identified in I. scapularis and A. americanum (Table 1.2) (11, 147).  
Additionally, Dermacentor reticulatus, secretes a salivary protein that binds both histamine 
and serotonin (Table 1.2) (129).  These proteins are likely essential for successful tick 
feeding as RNAi knockdown of A. americanum HBPs prevented successful tick feeding (4).  
Bradykinin Inhibitors  
Another important mediator of inflammation is bradykinin, which is generated during 
activation of the intrinsic coagulation cascade.  Bradykinin acts similarly to histamine, 
promoting pain, itch, and edema by increasing vascular permeability (99, 133, 147).  I. 
scapularis secretes a carboxypeptidase that degrades bradykinin, while B. microplus secretes 
a serine protease inhibitor that inhibits kallikrein, preventing the formation of bradykinin 
(Table 1.2) (123, 140).  Recently Ribeiro et al. demonstrated that sialostatin L and sialostatin 
L2 from I. scapularis saliva bind and inhibit cathepsin L, a protease implicated in kinin 
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generation, preventing inflammation (75, 76).  Sialostatin L and sialostatin L2 also display 
immunosuppressive functions.      
Anaphylatoxin Inhibitors     
 Anaphylatoxins are inflammatory mediators released during complement activation 
that induce vascular permeability, cause histamine release, and recruit inflammatory cells to 
sites of tissue damage (96, 145, 150, 151).  Ixodes ricinus and I. scapularis secrete salivary 
proteins that inhibit the alternative complement pathway, preventing the production of 
anaphylatoxins (Table 1.2) (20, 116, 124, 143, 146).  O. moubata also produces a 
complement inhibitor that binds C5, preventing its cleavage into the anaphylatoxin C5a 
(Table 1.2) (127).  By preventing the generation of anaphylatoxins, ticks inhibit the induction 
of inflammation allowing them to feed successfully. 
 
1.5 Immunosuppressive Tick Salivary Components               
 The host innate and adaptive immune responses are likely activated when blood 
sucking arthropods attach and begin feeding.  These immune responses can lead to the 
induction of inflammation and the activation and production of various components that 
result in host immune recognition and rejection.  Numerous blood sucking arthropods have 
evolved various salivary components to inhibit host innate and adaptive immune responses.  
As ixodid ticks uniquely feed on hosts for longer periods than most blood sucking 
arthropods, they have developed large families of salivary proteins that inhibit multiple host 
innate and adaptive immune mechanisms. 
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Inhibitors of endothelial cell adhesion molecule expression 
 During tissue damage or antigen stimulation, activated macrophages release cytokines 
that promote endothelial cells to express various surface adhesion molecules.  These 
molecules allow circulating leukocytes to attach to endothelial cells and eventually traverse 
the blood vessel wall, migrating to sites of tissue damage.  SGE from D. andersoni and I. 
scapularis significantly reduce the expression of several endothelial cell adhesion molecules 
in vitro and in vivo (Table 1.3) (87, 94).  In addition, expression of adhesion molecules on 
leukocytes is also reduced by I. scapularis saliva in vitro (95).  Expression of leukocyte 
adhesion molecules by endothelial cells and leukocytes is likely down-regulated during tick 
feeding, potentially preventing the initiation of innate immune responses and inflammation.    
Inhibitors natural killer cells, neutrophils, and macrophages 
 Activated natural killer (NK) cells are important lymphocytes in innate immunity as 
they are cytotoxic cells and release interferon-γ (IFN-γ), a cytokine that activates 
macrophages (1, 7, 14).  Neutrophils are polymorphonuclear leukocytes (PMN) that are 
activated during tissue damage and phagocytose invading organisms or cellular debris, 
inducing the production of reactive oxygen intermediates (ROIs) and releasing various 
granular constituents, including lysozyme.  Macrophages are phagocytic cells important in 
innate and adaptive immunity.  In innate immunity, macrophages function to phagocytose 
and kill invading microorganisms and secrete proinflammatory cytokines.     
When SGE of D. reticulatus, Amblyomma variegatum, Haemaphysalis inermis, and I. 
ricinus were incubated with natural killer cells, the activity of the cells was substantially 
decreased (Table 1.3) (73, 79, 80).  I. scapularis saliva also inhibited the activity of 
neutrophils, preventing the phagocytosis of Borrelia burgdorferi (95, 125).  SGE of I. 
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ricinus, R. sanguineus, and D. andersoni inhibited the killing of intracellular parasites and 
Borrelia afzelii, a causative agent of Lyme disease in Europe, by activated macrophages in 
vitro (27, 81, 114).  These inhibitory activities possibly prevent the activation of detrimental 
innate immune responses allowing successful tick feeding and facilitating efficient pathogen 
transmission.  
Antioxidants   
 ROIs generated by activated neutrophils and macrophages promote inflammation, 
tissue damage, and killing of invading microorganisms (1).  Even though ixodid ticks have 
rigid, sclerotized mouthparts that are likely not sensitive to ROIs, antioxidants, which inhibit 
the activities of ROIs, have been detected in the SGE of I. scapularis and H. longicornis 
(Table 1.3) (21, 142).  These antioxidants potentially aid the tick during extended feeding 
periods by preventing inflammation and activation of innate immune responses and by 
possibly protecting tick gut tissue. 
Cytokine and chemokine regulators 
 Cytokines and chemokines are vital for the initiation and development of innate and 
adaptive immune responses.  Cytokines mediate various inflammatory responses and 
stimulate the activation and proliferation of lymphocytes and effector cells, i.e. macrophages, 
while chemokines are chemoattractants for circulating neutrophils, basophils, lymphocytes, 
and monocytes, recruiting them to sites of tissue damage and inflammation (14, 99).  Since 
they are likely exposed to various immune components during their extended feeding 
periods, ixodid ticks have developed multiple strategies to inhibit the effects of cytokines and 
chemokines that include limiting their production and directly binding them to prevent their 
functions.   
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Multiple components in the saliva or SGE of I. ricinus, I. scapularis, Ixodes pacificus, 
D. andersoni, R. appendiculatus, and R. sanguineus reduce the expression and secretion of 
various proinflammatory cytokines, including IFN-γ, tumor necrosis factor-α (TNF-α), 
interleukin-1 (IL-1), and IL-6, thereby limiting the activation of inflammation and cell 
mediated immunity (TH1 immune responses) (Table 1.3) (27, 28, 36, 44, 74, 77, 78, 85, 98, 
111, 113, 131, 132).  Interestingly, the production of immunosuppressive cytokines, such as 
IL-4 and IL-10, is usually unchanged or enhanced by the saliva or SGE from these same tick 
species.  The production of IL-4 and IL-10 induces a TH2, or antibody-dependent, immune 
response.  In addition to producing factors that inhibit cytokines important for innate 
immunity, I. scapularis saliva also affects adaptive immunity by preventing secretion of IL-
2, a cytokine important for T-cell and B-cell proliferation from activated T-cells, and by 
expressing a salivary protein that directly binds IL-2 (40, 144).  Besides limiting the 
production and action of cytokines, components in saliva and SGE from A. variegatum, D. 
reticulatus, H. inermis, I. ricinus, R. appendiculatus, and R. sanguineus also bind and inhibit 
the activity of multiple chemokines, preventing the recruitment of immune cells to sites of 
tissue damage (Table 1.3) (33, 45, 46, 149).  
Inhibition of antigen presenting cells 
 Dendritic cells (DCs) and macrophages are important antigen presenting cells (APCs) 
in adaptive immunity that stimulate antigen specific T-cells through antigen presentation.  
DCs and macrophages normally reside in peripheral tissues in an inactive state.  Upon 
antigen or cytokine stimulation, activated DCs and macrophages engulf antigens and migrate 
to draining lymph nodes where they present antigens to CD4+ T-cells.  Saliva of R. 
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sanguineus inhibited the activation and migration of DCs in vitro, while I. scapularis saliva 
prevented CD4+ antigen T-cell stimulation in vitro (15, 106, 130).  
Inhibition of T-cell and B-cell proliferation  
 T- and B-cell activation is essential for the generation of adaptive immune responses, 
specifically cell-mediated immunity and antibody responses.  APCs present antigens to CD4+ 
T-cells through MHC class II complexes, causing activation, proliferation, and differentiation 
of the T-cells.  Upon activation, CD4+ T-cells secrete multiple cytokines and stimulate B-cell 
proliferation and maturation, which results in the generation of antibody secreting plasma 
cells (1).  I. scapularis saliva contains a protein, Salp15, which inhibits the activation of 
CD4+ T-cells by directly binding the CD4 coreceptor and inhibiting signaling pathways, 
resulting in a reduction of IL-2 production and inhibition of T-cell activation and 
proliferation (Table 1.3) (8, 38, 65).  Recently, Salp15 homologues have been identified in I. 
ricinus and I. pacificus, and recombinant Iris, an immunosuppressive protein from I. ricinus, 
was found to inhibit T-cell proliferation in vitro (53, 85).  D. andersoni and R. 
appendiculatus saliva also contains components that inhibits T-cell activation and 
proliferation in vitro (Table 1.3) (2, 9, 10, 27).     
B-cell proliferation, which eventually leads to the generation of antibody secreting 
plasma cells, is also inhibited by ixodid tick saliva.  Since IL-2 secreted by CD4+ T cells is 
important for B-cell proliferation, the IL-2 inhibitory activities of I. scapularis saliva likely 
inhibit B-cell proliferation (8, 40).  Proteins isolated from the saliva of I. ricinus and 
Hyalomma asiaticum inhibited lipopolysaccharide (LPS)-induced proliferation of B-cells in 
vitro (47, 164).  Furthermore, D. andersoni and R. sanguineus ticks reduced antibody 
responses in tick infested animals, suggesting salivary secretions from these ticks suppress 
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antibody production, possibly through inhibition of B-cell activation and proliferation (56, 
161).  Interestingly, B. microplus saliva altered the isotype of antibodies produced in 
susceptible hosts (68).  Ticks successfully avoid immune recognition by limiting T-cell and 
B-cell responses.  In addition, inhibition of adaptive immune responses also potentially 
facilitates the transmission of multiple pathogens.    
Immunoglobulin binding proteins 
 Besides limiting the activation and proliferation of B-cells, which ultimately prevents 
the production of antigen specific antibodies, ixodid also secrete salivary proteins that 
directly bind immunoglobulins.  Immunoglobulin binding proteins were detected in the 
hemolymph and SGE of R. appendiculatus, A. variegatum, and Ixodes hexagonus (Table 1.3) 
(152-154).  These proteins are speculated to be an important defense mechanism of the tick, 
allowing excretion host antibodies that may be detrimental to tick midgut tissues from the 
tick during feeding through the tick saliva.  
 
1.6 Host Complement Pathways 
 Activation of the complement pathways is an important host innate immune response 
generated during tick feeding.  Complement activation results in the production of 
anaphylatoxins, C3a and C5a, phagocytosis of opsonized invading organisms, and formation 
of the MAC in the outer surface of invading microbes leading to lysis of the organism (96, 
150, 151).  As the mouthparts of ticks are large, tough, rigid, sclerotized structures, they are 
unlikely to be affected by opsonization and MAC complexes.  However, MAC complexes 
generated from host complement activation may form in the membranes of tick midgut cells 
during ingestion of a blood meal, potentially disrupting feeding and causing lethality.  
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Anaphylatoxins are important for the recruitment of inflammatory mediators to sites of tissue 
injury and subsequent immune responses, potentially causing detrimental effects on feeding 
ticks.  Complement activation occurs through three different pathways, the MBL pathway, 
the classical pathway, and the alternative pathway (96, 150, 151).  Activation of the 
alternative complement pathway likely mediates tick rejection (160), either through the 
induction of inflammation or immune responses, as ixodid ticks specifically produce salivary 
components that inhibit this pathway (116).     
Classical and Mannose-Binding Lectin Complement Pathways 
The classical complement pathway is activated when IgG or IgM bind specific 
epitopes on the surfaces of invading organisms (Fig 1.2) (96, 150, 151).  C1q, a multimeric 
protein with globular head domains and a collagenous stalk, then binds the Fc protein of IgG 
or IgM.  Two molecules of C1r and C1s in the presence of Ca2+ subsequently bind C1q 
between the globular head domains.  After autoactivation, C1r cleaves and activates C1s, and 
C1s consequently cleaves C4 into C4a and C4b.  C4b covalently binds to amino or hydroxyl 
groups on activating surfaces through an exposed thioester group.  In the presence of Mg2+, 
C2 then binds to C4b and is cleaved by an adjacent C1s into C2b and C2a.  C2a remains 
bound to C4b, forming the classical pathway C3 convertase (C4b2a).  The C3 convertase 
then cleaves C3 into C3b and C3a (Fig 1.2). 
The MBL pathway is initiated when MBL, a multimeric molecule with globular 
domains and a collagenous stalk resembling C1q, binds mannose and N-acetyl glucosamine 
residues on the surfaces of invading microorganisms (Fig 1.2) (35, 96, 150, 151).  After 
attaching to surfaces, MBL-associated serine protease-1 (MASP-1) and MASP-2 interact 
with MBL.  Upon autoactivation, MASP-2 cleaves C4 and C2, generating the classical 
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pathway C3 convertase (C4b2a).  The classical and MBL complement pathways converge 
with the alternative complement pathway at the step of C3 cleavage by the C3 convertase 
(Fig 1.2).  
Alternative Complement Pathway     
 The alternative complement pathway is initiated when C3b covalently binds hydroxyl 
and amino groups on activating surfaces through an exposed thioester group (96, 109, 150, 
151) (Figure 1.3).  C3b is generated by the cleavage of C3 into C3a and C3b.  C3 is a large 
protein, composed of two chains, α and β, held together by a disulfide bond.  When C3 is 
cleaved, a small portion of the α-chain (C3a) is removed, leaving the remaining α-chain 
fragment bound to the β-chain (C3b).  Once C3b is covalently attached to a surface, fB then 
binds C3b in an Mg2+ dependent manner (Fig 1.2).  fD cleaves bound fB, releasing Ba and 
generating the alternative pathway C3 convertase (C3bBb).  The C3 convertase, either C4b2a 
or C3bBb, cleaves additional molecules of C3 into C3b and C3a, amplifying the complement 
cascades.  C3b then covalently binds more surfaces, forming more C3 convertases or causing 
opsonization.  C3b also binds to C3 convertases to form C5 convertases (C3bBbC3b or 
C4bC2a3b).   
Small of amounts of C3 are constantly hydrolyzed in biological fluids.  In order to 
generate C3b for alternative pathway initiation, hydrolyzed C3 (C3(H2O)), which 
functionally resembles C3b, binds fB in solution (96, 110).  fB is then cleaved by fD and the 
resulting complex, C3(H2O)Bb, cleaves C3, producing C3b that covalently attaches to 
activating surfaces.  Activation of the classical and MBL pathways also leads to the 
generation of C3b, which initiates the alternative pathway.     
 19
The late steps of complement activation result in the formation of the MAC.  C5 
convertases assembled from the classical, MBL, or alternative pathways cleave C5 into C5a 
and C5b (Fig 1.2) (96, 150, 151).  C5b, which is still attached to the C5 convertase, then 
binds C6.  Upon binding C6, C5 undergoes a conformational change exposing a membrane 
and C7 binding site.  When C7 binds to C5b, the resulting complex, C5b67, is released and 
associates with membranes.  C8 then binds C7, causing the complex, C5b-8, to insert into the 
membrane and form a small pore.  Multiple C9 molecules then bind the complex causing the 
formation of a large pore, the MAC, and lysis of the cell.  
Regulators of the Alternative Complement Pathway 
 The alternative complement pathway is both positively and negatively regulated by 
various factors.  Properdin is the only characterized natural positive regulator of the 
alternative pathway.  Properdin is a soluble plasma protein that directly binds both C3b, 
which increases its affinity for fB, and C3bBb, increasing its half-life more than ten-fold (26, 
51, 96).  Recent evidence has also demonstrated that properdin binds activating surfaces 
independently of C3b, thereby acting as a platform to recruit C3b and fB to the activating 
surface and initiate assembly of the C3 convertase (139).  Kimura et al. have established that 
serum from properdin deficient (properdin-/-) mice is incapable of alternative pathway 
complement activation in response to bacterial LPS or lipooligosaccharide (LOS) (71).  
Furthermore, Crry-deficient erythrocytes, which are susceptible to the alternative 
complement pathway in vivo, were not cleared when injected into properdin-/- mice.  The 
findings of these studies support an essential role for properdin in the initiation of the 
alternative complement pathway, in addition to its established role in C3 convertase 
stabilization. 
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 Several negative regulators of the alternative complement pathway are characterized, 
including fH, DAF, complement receptor 1 (CR1), and membrane cofactor protein (MCP) 
(96).  fH, a soluble plasma protein, directly interacts with C3b to cause displacement of Bb in 
the C3 convertase, resulting in destabilization and decay of the C3 convertase (108, 126, 158, 
159, 167).  fH also acts a cofactor for the serine protease fI, which cleaves C3b resulting in 
the formation of inactive C3b (iC3b) (Fig 1.3) (108, 126, 158, 159, 167).  Interestingly, when 
bound to C3b, properdin protects C3b from fH/fI mediated cleavage (96).  fH binding to C3b 
is primarily determined by the surface to which C3b is bound.  Deposition of “tickover” C3b 
is constantly occurring on host cell surfaces, but complement is not activated because 
negatively charged host cell surfaces rich in sialic acid promote binding of fH to C3b rather 
than fB (Fig 1.3).  Therefore, C3b is degraded when bound to host cell surfaces.  If C3b binds 
to the surface of invading microbes, which are deficient in sialic acid and are not negatively 
charged, fB favorably binds C3b rather than fH, promoting activation of the alternative 
complement pathway (96, 150).  
 DAF, a membrane anchored protein found on most cells including endothelial cells, 
erythrocytes, and leukocytes, protects the cells from the destructive effects of complement 
activation by directly binding the C3 convertase and accelerating its dissociation (34, 48, 52, 
102, 108).  CR1, a membrane anchored protein found on erythrocytes, monocytes, 
macrophages, lymphocytes, neutrophils, and eosinophils, acts as a decay accelerating factor, 
similar to DAF, and mediates fI degradation of C3b, similar to fH (25, 108, 126).  MCP, a 
membrane anchored protein found on circulating cells including platelets, granulocytes, 
lymphocytes, NK cells and monocytes, specifically binds C3b and acts as a cofactor for fI 
mediated degradation of C3b, similar to fH (96, 134, 135).  These negative regulators of the 
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alternative complement pathway serve important roles in protecting host cells from damage 
generated by inappropriate complement activation. 
 
1.7 Anti-complement Tick Salivary Proteins 
 Activation of the alternative complement pathway is an important host innate immune 
response triggered during tick feeding.  Ixodid and argasid ticks have evolved various 
mechanisms to inhibit complement activation, preventing the recruitment of inflammatory 
mediators and the induction of an inflammatory response.  I. scapularis saliva was originally 
found to specifically inhibit the alternative complement pathway as measured in vitro by the 
lysis of rabbit erythrocytes in the presence of NHS (116).  Additionally, Ribeiro also 
determined that C3b deposition on activating surfaces and C3a release were inhibited in the 
presence of I. scapularis saliva.  Several years later, Valenzuela et al. purified and 
characterized Isac from pooled SGE, which inhibited the alternative complement pathway 
(146).  Recombinant Isac (rIsac) expressed in transformed monkey kidney cells (COS-7) 
inhibited the alternative complement pathway by preventing the assembly of C3 convertases 
(C3bBb) on activating surfaces and dissociating preformed C3 convertases.  In addition to 
the anti-complement activity present in I. scapularis saliva, Lawrie et al. demonstrated that 
other ixodid tick saliva, specifically I. ricinus, I. hexagonus, and I. uriae saliva, also inhibited 
the alternative complement pathway (83).  I. ricinus SGE prevented the deposition of C3b on 
activator surfaces, the generation of C3a, and the cleavage of fB, suggesting inhibition of C3 
convertase formation (83, 84).  Recently, Daix et al. identified and expressed two members 
of a large family of anti-complement proteins in I. ricinus that share homology to Isac (20).  
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These proteins, Irac-1 and Irac-2, inhibit the alternative complement pathway by preventing 
the formation of C3 convertases and dissociating preformed convertases, similar to Isac. 
 Das et al. identified I. scapularis Isac homologues, Salp20 and Salp9, by screening a 
tick salivary gland cDNA library with serum from tick immune guinea pigs.  Salp20 and 
Salp9 have predicted masses of 20 kDa and 9 kDa, respectively, and share 83% and 50% 
identity to Isac at the amino acid level (21).  Together with Isac, Salp20 and Salp9 potentially 
comprise a family of I. scapularis anti-complement proteins, the ILP family.  In support of 
this observation, Soares et al. and Ribeiro et al. have identified several other potential 
members of this family that share sequence homology with Isac (117, 136).   
 The argasid tick, O. moubata, also expresses a salivary lipocalin, OmCI, which 
inhibits the classical and alternative complement pathways as measured by erythrocyte lysis 
(104, 127).  Recombinant OmCI produced in yeast cells contained N-linked glycosylations 
and prevented the generation of C5a in the presence of C5 convertases.  Nunn et al. further 
demonstrated that OmCI directly bound C5 preventing its cleavage by the C5 convertase.  
OmCI shares no homology with ILP family members or characterized regulators of 
complement. 
 
1.8 Saliva Activated Transmission of Pathogens  
 Not only do the anti-hemostatic, anti-inflammatory, and immunosuppressive 
components of tick saliva facilitate the tick during feeding, but they may also mediate saliva 
activated transmission (SAT) of various pathogens.  SAT is defined as the promotion of tick-
borne pathogen transmission through the action of tick salivary components on the host 
(105).  As the tick is salivating during feeding, it is secreting its anti-hemostatic, anti-
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inflammatory, and immunosuppressive components into the host and creating an 
immunosuppressed environment in which the pathogen enters.  Several tick-borne viruses 
and bacteria, including various species of Borrelia, have been shown to display enhanced 
infectivity in the presence of tick SGE (60-62, 82, 112).  In fact, I. scapularis Salp15 directly 
binds outer surface protein C (OspC) of B. burgdorferi, enhancing transmission of the 
pathogen to a murine host (115).  Currently, researchers are trying to characterize various 
tick salivary components with the goal of ultimately developing anti-tick vaccines that target 
different salivary components, potentially preventing successful tick feeding and pathogen 
transmission.     
 
1.9 Overview of thesis 
 A large family of I. scapularis salivary proteins related to Isac, the ILP family, which 
includes Salp20, has been discovered.  The function of additional related ILP family 
members and the necessity for such a large family of proteins during tick feeding are 
currently unknown.  As Salp20 and other ILP family members share substantial homology 
with Isac, it is likely they also display anti-complement activity.  Since ticks produce 
multiple members of this family, individual proteins likely display either structural or 
functional variability.  In order to address these possibilities, we have expressed several 
members of the ILP family and determined their functions.  In Chapter 2, we describe the 
expression and characterization of Salp20, which shares significant amino acid identity with 
Isac.  We also examine the potential role of this protein in the protection of various Borrelia 
species, suggesting a role for this salivary protein in pathogen transmission.  In Chapter 3, we 
determine the specific mechanism of complement inhibition used by Salp20.  We next 
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determine the functional activities and mechanisms of complement inhibition for additional 
ILP members in Chapter 4, with the goal of elucidating any differences that may exist 
between these family members.  We attempt to determine the purpose of producing multiple 
ILP family members.  Finally, in Chapter 5, we examine the necessity and importance of ILP 
family members during tick feeding.  We discuss the significance of these studies and the 
future goals of this project in Chapter 6.         
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Figure 1.1 Mouthparts and depictions of ticks.  A. Ventral and dorsal views of the 
mouthparts of Ixodes scapularis, containing the palps (P), chelicerae (C), and hypostome (H), 
are pictured.  B. Illustrations of representative “soft” and “hard” ticks are depicted.  Figure 
adapted from (137) and (42).       
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Table 1.1 Anti-hemostatic tick salivary proteins. 
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Table 1.2 Anti-inflammatory tick salivary proteins. 
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Table 1.3 Immunosuppressive tick salivary proteins. 
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 Figure 1.2 The classical, alternative, MBL complement pathways.  The classical pathway is 
initiated when C1q binds surface bound IgG or IgM.  C1s and C1r then bind C1q, and C1s 
cleaves C4 into C4a and C4b.  C4b covalently binds an activating surface, allowing C2 to 
bind.  C2 is then cleaved by C1s, resulting in the formation of the C3 convertase, C4b2a.  
The MBL pathway is initiated when MBL binds carbohydrate residues on activating 
surfaces.  MASP-1 and MASP-2 then bind MBL, and MASP-2 cleaves C4 and C2 to form 
the C3 convertase, C4b2a.  The alternative pathway is initiated when C3b covalently binds 
activating surfaces.  Factor B then binds C3b and is cleaved by fD, resulting in the formation 
of the C3 convertase, C3bBb, which is stabilized by properdin.  The C3 convertase cleaves 
additional C3 molecules that opsonize surfaces, generate additional convertases, or bind C3 
convertases to produce C5 convertases.  C5 convertases cleave C5, which initiates activation 
of the late steps of complement and ultimately leads to the formation of MACs in the cell 
membrane.  Figure taken from (150) with permission from publisher.  
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Figure 1.3 Regulatory activities of fH and fI in the presence of bound C3b.  C3 is cleaved, 
generating C3b, which contains an exposed thioester group.  This thioester allows C3b to 
bind covalently to the surfaces of either host cells or invading microbes.  If C3b binds to host 
cell surfaces, which are typically negatively charged due to the presence of sialic acid, fH 
preferably binds to C3b.  fH then acts as a cofactor for fI mediated degradation of C3b into 
inactive C3b (iC3b) and C3f.  If C3b binds to microbial surfaces, which are typically not 
negatively charged due to a lack of sialic acids, fB preferably binds C3b.  fB is subsequently 
cleaved by fD, releasing Ba and leaving Bb bound to C3b, or the C3 convertase.  The C3 
convertase is stabilized by properdin and cleaves additional C3 molecules into C3b and C3a.  
C3b then binds more sites on the activating surface or binds the C3 convertase to form a C5 
convertase.  Figure taken from (150) with permission from the publisher.
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2.1 Abstract 
 Ixodes ticks are vectors of several pathogens including B. burgdorferi.  Tick saliva 
contains numerous molecules that facilitate blood feeding without host immune recognition 
and rejection.  We have expressed, purified, and characterized Salp20, a potential inhibitor of 
the alternative complement pathway that shares homology with the Isac protein family.  
When analyzed by SDS-PAGE and size exclusion chromatography, Salp20 was 
approximately 48 kDa, more than double its predicted mass, primarily due N- and O-linked 
glycosylations.  Recombinant Salp20 inhibited the alternative complement pathway by 
dissociating the C3 convertase, and partially protected a serum sensitive species of Borrelia 
from lysis by NHS.  We propose that Salp20 facilitates tick feeding and possibly protects 
tick-borne pathogens from complement components.
 
2.2 Introduction 
 The deer tick, I. scapularis, transmits several pathogens including Anaplasma 
phagocytophilum, Babesia microti, and B. burgdorferi, the causative agent of Lyme disease 
and most prevalent vector-borne pathogen in the United States and Europe (3, 36).  I. 
scapularis ticks typically feed on their natural hosts for several days without rejection by the 
host immune system due to several anti-hemostatic, vasodilatory, and immunosuppressive 
components present in their saliva (4, 7, 14, 35, 36). Salivary proteins capable of eliminating 
host pain and irritation at the feeding site include histamine binding proteins, apryases, 
prostaglandins, and kininases (16, 19, 22, 29).  In addition, tick saliva also impairs natural 
killer cell activity, reduces circulating and localized antibodies, suppresses T-cell 
proliferation, and decreases the production of Th1 cytokines (6, 7, 9, 21, 28, 36).  Ixodes sp. 
salivary gland extracts and saliva inhibit the alternative pathway of complement and prevent 
the production of anaphylatoxins (7, 11, 12, 19, 23, 36). 
An I. scapularis salivary protein, Isac, with a predicted mass of 18 kDa, inhibits the 
alternative pathway of complement by dissociating the components of the C3 convertase and 
preventing the deposition of C3b onto surfaces, similar to fH and factor H-like protein 1 (8, 
13, 28, 33).  The alternative pathway of complement is activated when C3b binds covalently 
through its reactive thioester to activating surfaces (5, 13, 24, 31, 32).  Surface bound C3b 
binds fB, which is then cleaved by fD, producing the cleavage products Bb and Ba.  Bb 
remains bound to C3b, while Ba is released.  The surface bound C3bBb complex, or C3 
convertase, cleaves additional C3 components producing more C3b that either binds to 
activating surfaces or to the C3 convertase, forming the C5 convertase.  The C5 convertase 
then initializes the formation of the MAC.   
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The alternative complement pathway can be initiated by metastable C3(H2O), a 
naturally occurring hydrolyzed C3 molecule.  C3(H2O) resembles C3b and binds fB in 
solution, allowing fB to then be cleaved by fD.  The resulting fluid-phase convertase, 
C3(H2O)Bb, then cleaves C3, releasing C3b that deposits onto surfaces activating the 
complement cascade (13, 17, 24).   
Invading microbes coated with C3b are either eventually lysed by the development of 
the MAC or phagocytosed by macrophages and neutrophils.  In addition to mediating lysis 
and opsonization of invading pathogens, the alternative complement cascade also leads to the 
production of anaphylatoxins, which are proinflammatory mediators that recruit neutrophils 
and monocytes to the site of complement activation (5, 13, 31, 32).   
Inhibition of the alternative complement pathway by I. scapularis is important for 
preventing host inflammation and immune recognition at the feeding site, allowing the tick to 
feed successfully to repletion.  In addition, inhibition of the alternative complement pathway 
by tick saliva during feeding potentially allows the successful transmission of pathogens 
throughout the feeding period of 5 days.   
Two other I. scapularis salivary proteins, Salp9 and Salp20, sharing homology with 
Isac were identified from a nymphal I. scapularis salivary gland cDNA library (4).  Salp9 is a 
protein with 50% similarity to Isac and a predicted mass of 8.8 kDa.  Salp20 is a protein with 
83% similarity to Isac and a predicted mass of 20.4 kDa.  These three salivary proteins, 
Salp9, Salp20, and Isac, are included in a large family of related I. scapularis salivary 
anticomplement proteins recently identified by Soares et al. (25) and Ribeiro et al. (20).  
Interestingly, when RNAi was used to silence isac in I. scapularis nymphs, tick feeding was 
 49
delayed and the average weight of engorged ticks was reduced, indicating the importance of 
anticomplement proteins for successful tick feeding (25).   
The goal of the current study was to identify the properties and characterize the 
functions of Salp20, which shares homology with the I. scapularis salivary anti-complement 
protein Isac.  We identified additional members of the Isac protein family that share 
homology with both Salp20 and Isac.  We demonstrated that recombinant Salp20 purified 
from the media of insect cells inhibits the alternative complement pathway by dissociating 
the components of the C3 convertase and preventing the cleavage of C3 and the deposition of 
C3b onto cell surfaces.  Additionally, we established that Salp20 protects serum sensitive 
strains of Borrelia from complement mediated lysis indicating that tick transmitted 
pathogens potentially benefit from the activity of Salp20 and related protein family members. 
 
2.3 Materials and Methods 
Ticks and tick saliva 
Ixodes scapularis ticks were raised as previously described by Sonenshine (26).  Tick 
saliva was produced following a modified protocol from Tatchell et al. (27).  Briefly, adult 
ticks were allowed to feed on New Zealand White rabbits for 5 days.  The ticks were 
removed and attached to glass slides with adhesive tape.  Capillaries were placed over the 
mouthparts, and ~1-2 µL of pilocarpine (25 mg/ml) and dopamine (25 mg/ml) in 95% 
ethanol were applied on the dorsum of the ticks. The ticks were allowed to salivate into the 
capillaries ~2 hrs. at 27oC in humidity chambers.  
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Cell lines and media 
 Adherent cultures of High Five cells (Invitrogen, Carlsbad, CA), derived from the 
cabbage looper, Trichoplusia ni, were seeded and maintained according to the instructions of 
the manufacturer.  The cells were grown in Express Five Serum free media (SFM) (Gibco, 
Carlsbad, CA) supplemented with L-glutamine (18 mM) (Gibco, Carlsbad, CA), penicillin 
(100 U/ml), streptomycin (100 µg/ml), and fungizone (0.25 µg/ml) (Gibco, Carlsbad, CA) at 
28oC.  
 Borrelia burgdorferi B31C1 and Borrelia garinii (ATCC, Manassas, VA) were 
grown and maintained in complete BSK-II media at 33oC as described by Ohnishi et al. (15).   
PCR from I. scapularis bacteriophage libraries 
   In order to construct the cDNA library from 48 hr fed nymphs, total RNA was first 
extracted from ~300 fed I. scapularis nymphs using the ToTALLY RNA extraction kit 
(Ambion, Austin, TX) according to the instructions of the manufacturer.  Isolation and 
purification of mRNA from total RNA was performed using the poly(A)Pure mRNA 
Purification Kit (Ambion, Austin, TX). The cDNA library from 48 hr fed nymphal ticks was 
subsequently constructed in the phagemid vector, pBK-CMV, using the ZAP Express cDNA 
Synthesis and ZAP Express cDNA Gigapack III Gold Cloning Kit (Stratagene, La Jolla, CA).  
The average size of an insert in the phagemid vector was approximately 1.8 kilobases (kb).  
The titer of the resulting phage library was 2.0 x109 plaque forming units (pfu)/ml with a 
complexity of 1.0 x 106 clones.  The method used to generate the cDNA library generated 
from fed nymph salivary glands has been described previously (4).   
 Products were PCR amplified from each of the bacteriophage libraries directly using 
the following primer sets: KS20F – 5` CCAGCCATGAGGACTGCGCT 3` and S20R – 5` 
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TCAGGAAATTGCCTCGAAT TGAGT 3`, and IsacF – 5` CACTGAGGTTC 
AGAGCAAG 3` and IsacR – 5` GTATCAGAACTGTGCTTGCAC 3`.  The Salp20 primers, 
KS20F and S20R, anneal to the 5` and 3` ends of the salp20 open reading frame (ORF), 
while the Isac primers, IsacF and IsacR, anneal upstream and downstream of the isac ORF, 
respectively.  After amplification, the PCR products were cloned into pCR2.1 TOPO 
following the instructions of the manufacturer (Invitrogen, Carlsbad, CA). Plasmids 
containing the PCR products were purified using the QIAprep Mini-Prep Kit (Qiagen, 
Valencia, CA) and then transformed into chemically competent E. coli TOP 10 cells.  
Transformants were selected and screened by restriction digests of plasmid DNA and PCR 
analysis using M13F and M13R primers (Invitrogen, Carlsbad, CA), which anneal outside of 
the multiple cloning region of pCR2.1 TOPO.  To determine the identity of the PCR 
products, plasmids containing inserts of the correct size were sequenced using the M13 
primers at the UNC-Chapel Hill Genome Analysis Facility.      
Expression and purification of recombinant Salp20 in High Five cells 
 To express Salp20 in High Five cells, we used an approach similar to Alarcon-
Chaidez et al. (1).  Salp20 was first PCR amplified from the pBlue vector using the following 
primers: KS20F – 5` CCAGCCATGAGGACTGCGCT 3`, and S20RNS – 5` 
GGAAATTGCCTCGAATGAGTCTC 3`.  The 5` primer contained a Kozak sequence to 
allow for efficient protein expression from the cloning vector, while the 3` primer lacked a 
stop codon to allow the fusion of a V5-epitope and 6X-histidine (His) tag to the C-terminus 
of the protein.  Once amplified, the PCR product was cloned into the expression pIB/V5-His-
TOPO (Invitrogen), which contains both ampicillin and blasticidin resistance genes allowing 
for selection in E. coli and High Five cells, generating the construct pIB-S20NS.  
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Constitutive expression of Salp20-V5-His (S20NS) was controlled by the Orgyia 
pseudotsugata baculovirus promoter, OpIE2.  The resulting construct, pIB-S20NS, was 
purified using the QIAfilter Plasmid Midi Kit (Qiagen, Valencia, CA) and transfected into 
High Five cells following the manufacturer’s protocol.  As a positive control for protein 
expression and purification, High Five cells were also transfected with pIB-CAT (Invitrogen, 
Carlsbad, CA), the pIB/V5-His vector containing chloramphenicol acetyltransferase (CAT).  
Stably transfected cells were selected and maintained by the addition of blasticidin (10 
µg/ml) to the cell culture media. 
 For protein purification, adherent cultures of stably transfected cells were grown to 
90% confluency in T-175 flasks.  Cells were then collected and seeded into 500 ml of culture 
media in 3L Fernbach flasks (Corning, Corning, NY) at a density of 5 x 105 cells/ml.  
Cultures were grown at 28oC with gentle agitation until reaching a density of 2-3 x 106 
cells/ml in 1L.  The media was then collected and centrifuged to remove all cells and debris.  
After centrifugation, the media was dialyzed 24 hrs. at 4oC against Ni-NTA Wash Buffer (50 
mM NaH2PO4, 300 mM NaCl, pH 8.0).  Throughout dialysis, the buffer was changed three 
times.  After dialysis, the media was loaded onto a 500 µL column of Ni2+-Nitriloacetic acid 
(Ni-NTA, Qiagen, Valencia, CA) agarose.  After all media passed through the column, the 
column was washed two times with 4 column volumes of Ni-NTA Wash Buffer, and eluted 
four times with ½ the column volume of Ni-NTA Elution Buffer (50 mM NaH2PO4, 300 
mM NaCl, 500 mM imidazole, pH 8.0).  All elutions were pooled and dialyzed 24 hrs. at 4oC 
against phosphate buffered saline (PBS) with two buffer changes.  After dialysis, the elution 
sample was concentrated using Amicon Ultra-15 YM-10 centrifugal filter devices (10 kDa 
MWCO, Millipore, Billerica, MA).  Protein concentrations and purity were determined by 
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Bradford analysis and SDS-PAGE, respectively.  The final concentration of protein was 50-
100 µg/ml.  Purified protein was stored at -20oC until needed.   
SDS-PAGE and Immunoblot or Lectin Blot Analysis 
 For SDS-PAGE, all samples were electrophoresed under reducing conditions by 
either 10% SDS-PAGE or 4-12% SDS-PAGE.  Gels were then stained using SimplyBlue 
SafeStain (Invitrogen, Carlsbad, CA) following the instructions of the manufacturer.  For 
immunoblots, following separation by SDS-PAGE under reducing conditions, samples were 
transferred to nitrocellulose membranes by semi-dry transfer at 380 mA for 60 min.  
Membranes were then blocked with 1X Tris-buffered saline (TBS), 2% milk for 12-16 hrs at 
4oC.  Mouse anti-V5 monoclonal antibody (Invitrogen, Carlsbad, CA) was diluted 1:5000 in 
1X TBS, 2% milk and incubated with membranes for 1 hr at room temperature.  Membranes 
were next incubated with alkaline phosphatase (AP) conjugated goat anti-mouse antibody 
(Sigma, St. Louis, MO) diluted 1:1000 in 1X TBS, 2% milk for 45 min at room temperature.  
For C3a blots, rabbit anti-human C3a antibody (CompTech, Tyler, TX) was diluted 1:1000, 
and secondary AP-conjugated goat anti-rabbit IgG (Sigma) was diluted 1:1000 in 1X TBS, 
2% milk.  For C3 blots, goat anti-human C3 antibody (CompTech, Tyler, TX) was diluted 
1:1000, and AP-conjugated rabbit anti-goat IgG (Sigma, St. Louis, MO) was diluted 1:25000 
following the same procedures as described.  Incubation times were the same as described 
previously.  Bound antibody was detected directly on the membranes using the phosphatase 
substrate, 5-bromo-4-chloro-3-indolyl-phosphate/nitroblue tetrazolium (BCIP/NBT) (KPL).  
For lectin blots, blots were subjected to the DIG Glycan Differentiation Kit (Roche, 
Indianapolis, IN) following the instructions of the manufacturer.  Briefly, blots were blocked 
and incubated with digoxigenin (DIG)-labeled lectins at various dilutions.  Blots were then 
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washed and incubated with AP-conjugated sheep anti-DIG Fab fragments.  Bands were then 
visualized with diluted NBT/X-phosphate staining solution.     
Deglycosylations with Peptide N-Glycosidase F (PNGase F) and 
trifluoromethanesulfonic acid (TFMS) 
 To remove N-linked glycans from S20NS, approximately 0.5 µg of purified S20NS 
from insect cells was digested with 30 U/µL of PNGase F (New England Biolabs, Ipswich, 
MA) following the instructions provided by the manufacturer.  Briefly, protein was denatured 
in 1X Glycoprotein Denaturing Buffer (0.5% SDS, 1% β-mercaptoethanol) (New England 
Biolabs, Ipswich, MA) for 10 min at 100oC.  The denatured protein was then incubated with 
PNGase F in 1X G7 Buffer (50 mM sodium phosphate, pH 7.5, New England Biolabs, 
Ipswich, MA) and 1% NP-40 for 24 hr at 37oC.  The deglycosylated protein was then 
analyzed by SDS-PAGE and immunoblots. 
 To remove N- and O-linked glycans from S20NS, 2 µg of S20NS were treated with 
the Glycoprofile IV Chemical Deglycosylation Kit containing TFMS according to the 
manufacturer’s instructions (Sigma, St. Louis, MO). 
Rabbit Erythrocyte Lysis Assays 
 RbEs (CompTech, Tyler, TX) were washed three times with 5 volumes of alternative 
pathway (AP) Buffer (5 mM MgCl2, 5 mM EGTA in gelatin veronal buffer (GVB), 
CompTech, Tyler, TX), and resuspended to a final concentration of 2.0 x 108 cells/ml in AP 
buffer.  Prior to performing the alternative pathway assays, the dilution of NHS (CompTech, 
Tyler, TX) resulting in 80-90% lysis of the RbEs was determined and used for experimental 
assays.  Experimental and control proteins were serially diluted in PBS and added to NHS in 
AP buffer.  For some experiments, equal amounts of C5 depleted (C5-/-) human serum 
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(CompTech, Tyler, TX) were used instead of NHS.  The volume of protein sample used for 
each reaction remained constant, keeping concentrations of divalent cations and chelators 
invariable.  The final volume of the mixture was 25 µl.  This mixture was then incubated 
with 25 µl of washed, resuspended RbEs (2 x 108 cells/ml) in disposable borosilicate glass 
culture tubes for 30 min at 37oC.  Control reactions contained RbEs (2 x 108 cells/ml) 
incubated with only NHS in AP buffer or AP buffer alone. After incubation, 75 µl of N-
saline (0.15 M NaCl) was added to each tube.  The tubes were then centrifuged at 1000 g for 
5 min to pellet all remaining intact RbEs.  Supernatants were collected and loaded into 96-
well plates.  The O.D. of the supernatants was measured at a λ of 405 nm. 
Human C3 or fB deposition ELISAs  
To determine if Salp20 inhibited the deposition of human C3 or fB onto surfaces, we 
performed deposition ELISAs using agarose coated plates following a modified protocol of 
Ribeiro and Valenzuela et al. (19, 28).  In the presence of polysaccharides, C3 is activated 
and covalently attaches to the sugars (30).  Factor B then noncovalently binds bound C3b.  
Since agarose is made of primarily galactose, C3 is activated in the presence of agarose and 
attaches covalently to agarose surfaces (19, 28).  Briefly, 96-well plates were coated with 100 
µl of 0.1% agarose in water.  The agarose in the plates was dried for 48 hrs at 37oC.  Once 
dry, 50 µl of AP buffer containing a 1:4 dilution of NHS, and either S20NS or CAT at 
various concentrations was added to the wells and incubated at 37oC for 30 min.  In some 
reactions, S20NS or CAT was added 30 min after the addition of NHS and the wells were 
incubated an additional 20 min at 37oC.  Control wells lacked NHS or contained 25 mM 
EDTA and NHS.  After incubation with NHS, the plates were washed 3 times, 5 min each on 
an orbital shaker, with 200 µl/well of 1X TBS containing 10 mg/ml bovine serum albumin 
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(BSA) and 2 mM MgCl2+.  After washing, 100 µl of a 1:1000 dilution of goat α-human C3 
antibody (CompTech, Tyler, TX) or goat α-human fB antibody (CompTech, Tyler, TX) in 
1X TBS, 10mg/ml BSA, 2mM MgCl2+ was added to each well and the plate was incubated 1 
hr at 37oC.  The plate was then washed 3 times as previously described, and 100 µl of either a 
1:5000 or 1:1000 dilution of an AP-conjugated rabbit α-goat IgG (Sigma, St. Louis, MO) 
was added to each well.  The plate was incubated 45 min at 37oC.  Following the incubation, 
the plate was washed 2 times, 5 min each, with 200 µl/well of 1X TBS, 10 mg/ml BSA.  The 
plate was next washed once with 1X TBS, 10 mg/ml BSA, 0.1% Tween followed by an 
additional wash with N-saline.  After washing, 100 µl of Sigma Fast p-Nitrophenyl 
phosphate (PNPP, Sigma, St. Louis, MO) was added to each well and the plate was incubated 
at room temperature for 15 min.  After incubation, the O.D. was measured at a λ of 405 nm.    
Bactericidal Assays 
 Bactericidal assays were performed following a modified protocol of Brooks et al (2).  
Briefly, B. burgdorferi (serum resistant) and B. garinii (serum sensitive) were grown in BSK-
II media at 33oC to a density of 1-5 x 107 cells/ml.  Cells were collected and washed 2 times 
with serum free BSK-II.  Cells were then resuspended at a density of 1 x 107 cells/ml in 
serum-free BSK-II containing either 20% NHS, 20% heat-inactivated NHS (HI NHS), 
S20NS (10 µg/ml), CAT (10 µg/ml), or 1X PBS.  The bacteria were then incubated at 33oC 
for 1 hour in the presence of NHS, HI NHS, or NHS and S20NS or various controls.  After 
incubation, live bacteria were counted by dark field microscopy.  Spirochetes were 
considered live if they were moving and maintained their morphology and refractiveness.  
The lower detection limit of the assay was 5 x 104 cells/ml.   
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2.4 Results 
Isac and Salp20 are members of a large family of proteins 
 Soares et al. (25) and Ribeiro et al. (20) have identified multiple cDNA clones from 
adult and nymphal cDNA libraries that share homology with Isac and Salp20.  In this study, 
we have discovered an additional 15 unique clones related to Isac and Salp20, increasing the 
size of the Isac protein family.  In order to identify members of this family, we PCR 
amplified products using two primer sets, S20F & S20R and IsacF & Isac R, from two 
different cDNA libraries, one generated from the salivary glands of fed I. scapularis nymphs 
and the other from whole fed I. scapularis nymphs.  We sequenced the PCR products and 
identified 15 unique clones sharing homology with Isac and Salp20 (Fig 2.1).  The translated 
amino acid sequences of each of the isolated clones ranged from 69-95% sequence similarity 
to Isac and Salp20.  Twelve of the 15 unique clones contained a 5-10 amino acid deletion at 
positions 134 through 146 (Fig 2.1).  Additionally, S20Lclone 5 contained a frameshift 
mutation at position 171 altering the location of the stop codon by 3 amino acids.  In all of 
the clones identified, a putative secretion signal was present, four cysteines in the mature 
protein were conserved, and four of the seven N-linked glycosylation sites found in Isac and 
Salp20 were maintained (Fig 2.1).  
Production and purification of Salp20 from E. coli and High Five cells 
In order to determine if other members of the Isac protein family shared the 
complement inhibitory properties of Isac, we expressed recombinant Salp20 in insect cells 
for use in functional assays.  For insect cell expression, a V5 epitope and 6X-histidine tag 
were fused to the C-terminus of Salp20, which was expressed with its native putative N-
terminal secretion signal.  Insect cells were stably transfected with pIB-S20NS vector to 
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produce recombinant Salp20-V5-His (S20NS).  To evaluate expression of S20NS, cell 
lysates and media were collected and analyzed by Western blot analysis using a monoclonal 
antibody directed against the V5-epitope tag (Fig 2.2).  As seen in the blot, S20NS is present 
as a smear in the media of the transfected cells due to its native secretion signal.  Some 
S20NS is also found in the cell lysates.   
To purify S20NS from cell media, we subjected media from stably transfected cells to 
immobilized-metal affinity chromatography.  All fractions were collected and analyzed by 
SDS-PAGE (Fig 2.3).  Roughly 50-100 µg of S20NS was purified from 1 liter of cell media.  
Unexpectedly, S20NS was approximately 48 kDa, much larger than the expected size of 24 
kDa, which is the mass of Salp20 containing the C-terminal V5-epitope and 6X-histidine tags 
(4 kDa) (Fig 2.3).  Size exclusion chromatography also indicated that the mass of the protein 
was approximately 48 kDa (data not shown).  In order to confirm the identity of S20NS, the 
purified protein sample was analyzed by mass spectroscopy at the UNC-Duke Michael 
Hooker Proteomics Center.  By mass spectroscopy, we attained 30% peptide coverage of 
S20NS, with the majority of the peptides corresponding to only S20NS (data not shown).  
Glycosylation Status of S20NS 
 We believed S20NS was approximately 48 kDa rather than 24 kDa due to post-
translational modifications, including N-linked and O-linked glycosylations.  Sequence 
analysis of S20NS reveals 7 potential N-linked glycosylation sites based on the consensus 
sequence Asn-X-Ser/Thr (Fig 2.1) and 8-14 O-linked glycosylation sites within the C-
terminus (20) as predicted by NetOGlyc 3.1 server, indicating the protein could display a 
large mass due to presence of carbohydrates.  In addition, when analyzed by Western blots, 
S20NS appears as a smear possibly representing differentially glycosylated forms of the 
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protein (Fig 2.2).  To determine if N-linked sugars were responsible for the size increase of 
S20NS, we digested S20NS with PNGase F, a glycosidase that removes N-linked 
carbohydrates.  After digestion with PNGase F, S20NS shifted from 48 kDa to approximately 
38 kDa (Fig 2.4A), indicating S20NS contained N-linked glycosylations.  However, the 
protein did not shift to the expected size of 24 kDa.  In addition, mass spectroscopy of 
S20NS treated with PNGase F indicated the addition of N-linked carbohydrates at 2 potential 
sites. 
 In order to determine if S20NS contained O-linked glycosylations in addition to N-
linked glycosylations, we treated S20NS with trifluoromethanesulfonic acid (TFMS), which 
removes N- and O-linked glycans without destroying the peptide backbone.  After TFMS 
treatment, S20NS shifted from 48 kDa to approximately 30 kDa (Fig 2.4A), indicating both 
N- and O-linked glycosylations were primarily responsible for the size shift of S20NS.  The 
smear below 30 kDa after S20NS was treated with TFMS is most likely the result of protein 
degradation (Fig 2.4A).   
To confirm S20NS contained both N- and O-linked glycans, we subjected S20NS and 
S20NS digested with PNGase F or treated with TFMS to lectin blotting using the lectin 
Glanthus nivalis agglutinin (GNA), which recognizes terminal mannose residues.  GNA 
recognized S20NS and S20NS treated with PNGase F (Fig 2.4B), indicating PNGase F 
partially removed N-linked carbohydrates, leaving O- and some N-linked sugars on S20NS.  
After TFMS treatment, S20NS was no longer recognized by GNA (Fig 2.4B), suggesting all 
carbohydrates, both N- and O-linked had been removed.        
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Alternative Complement Pathway Assays with S20NS 
Small quantities of I. scapularis saliva are capable of inhibiting the alternative 
pathway of complement (Fig 2.5A).  Valenzuela et al. (28) demonstrated that Isac, a tick 
salivary protein with 83% amino acid sequence similarity to Salp20, inhibited the alternative 
complement pathway.  To determine if S20NS inhibited the alternative complement pathway, 
we incubated RbEs with NHS and S20NS in the presence of Mg2+.  After incubation, we 
removed any whole cells or cellular debris by centrifugation.  We then calculated the percent 
lysis of the RbEs by measuring the optical density of the supernatants.  As little as 0.625 
µg/ml of S20NS inhibited the alternative complement pathway by approximately 70% (Fig 
2.5B), indicating S20NS functions similarly to Isac.  Interestingly, the percent inhibition by 
S20NS did not increase beyond 70% with increasing concentrations of S20NS.  Cell culture 
media from chloramphenicol acetyltransferase-V5-His (CAT) expressing High Five cells that 
was subjected to the same purification procedures as S20NS media and E. coli expressed 
Salp20 did not inhibit RbE lysis at any concentration (Fig 2.5B and data not shown, 
respectively), indicating that only S20NS produced in insect cells had anti-complement 
activity.  S20NS did not inhibit the classical complement pathway (data not shown), 
consistent with Isac, tick saliva, and salivary gland extracts (11, 34). 
Effect of S20NS on the cleavage and activation of C3 
 Since S20NS inhibited the alternative complement pathway, we next wanted to 
determine the step of the alternative pathway that was blocked by S20NS.  Activation of the 
alternative pathway begins with the covalent attachment of C3b to activating surfaces (13, 
24, 31, 32).  fB then binds surface bound C3b, allowing cleavage of fB into Bb and Ba by fD.  
The surface bound C3bBb complex, C3 convertase, then cleaves additional C3, allowing 
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amplification of the pathway by the deposition of more C3b onto surfaces.  In order to 
examine the cleavage state of C3 in the presence of S20NS, we analyzed supernatants and 
erythrocyte cell pellets from RbE lysis assays by immunoblots. We performed the RbE lysis 
assays with C5 (C5-/-) depleted human serum to allow deposition of C3b on cell surfaces but 
prevent complete lysis of the erythrocytes by the membrane attack complex.  Supernatants 
and cell pellets were subjected to Western blot analysis to determine if C3 was cleaved into 
C3a and C3b, and if C3b deposition occurred on RbE surfaces.  At a concentration of 10 
µg/ml, S20NS significantly reduced the production of C3a from the cleavage of C3 when 
compared to reactions containing only PBS as indicated by the lower band (Fig 2.6A).  When 
present in lower concentrations, S20NS had little effect on C3 cleavage.  In the blots, the 
upper band represents the α-chain of C3 and the middle bands represent the α-chain of 
iC3(H2O) and an α-chain degradation product of C3 (~ 45 kDa).    
C3 and C3b are composed of two chains, the α- and β-chains (13).  When activated, 
the α-chain of C3 covalently attaches to a surface through its reactive thioester.  The β-chain 
of C3 remains attached to the covalently bound α-chain by a disulfide bond.  In the blot 
shown, S20NS (10 µg/ml) prevented the covalent attachment of the C3b to RbE surfaces 
when compared to pellets from reactions containing only PBS, as indicated by the upper 
arrow representing covalently attached C3b α-chains  (C3 α`-chains) and the middle arrow 
representing C3b β-chains. (Fig 2.6B).  Under the reducing conditions of SDS-PAGE, the β-
chain dissociates from the α-chain of C3b.  The lower arrow indicates C3b α-chain 
degradation products.  Purified CAT protein containing the C-terminal V5 epitope and 6X-
His tag (CAT) had no effect on the cleavage of C3 or the deposition of C3b at equivalent 
concentrations.  No protein was detected in the reaction containing NHS and PBS because no 
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cell pellet formed due to presence of all complement components, including C5, in NHS 
causing complete lysis of the erythrocytes.   
To further determine how S20NS was acting to prevent C3a production and C3b 
deposition, we performed C3 and fB deposition ELISAs following the protocol of 
Valenzuela et al. (28).  In this system, C3 is activated in the presence of Mg2+ and agarose 
and covalently deposits to agarose coated wells of a 96-well plate (28, 30).  Factor B then 
noncovalently attaches to agarose-bound C3b, forming the C3 convertase.  S20NS (10 
µg/ml) inhibited the deposition of both C3b and fB when added immediately with NHS to the 
agarose coated wells (Fig 2.7A and 2.7B, respectively).  However, when added 30 min after 
the addition of NHS, S20NS (10 µg/ml) did not displace covalently bound C3b from the 
agarose (Fig 2.7A).  Interestingly, S20NS (10 µg/ml) displaced fB from covalently bound 
C3b when added 30 min after the addition of NHS (Fig 2.7B). These data indicate S20NS 
works similarly to Isac, dissociating fB from covalently bound C3b and disrupting the 
activity of the C3 convertase. 
Borreliacidal Assays with S20NS 
 Recently, Kyckova et al. have demonstrated I. ricinus salivary gland extracts protect 
B. afzelii from complement mediated lysis in vitro (10).  Since S20NS is an I. scapularis 
salivary protein secreted into a host during feeding and pathogen transmission, the 
anticomplement activity of S20NS could potentially protect vector transmitted pathogens 
from complement mediated killing.  To address this hypothesis, we performed bactericidal 
assays with NHS, S20NS (10 µg/ml), and a serum sensitive species of Borrelia.  In the 
presence of 20% NHS, S20NS protected Borrelia garinii, a serum sensitive species of 
Borrelia causing Lyme disease in Europe, from complement mediated killing by 
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approximately 70% (Fig 2.8).  B. burgdorferi, a serum resistant species of Borrelia, was 
unaffected by NHS in presence or absence of S20NS.  
         
2.5 Discussion  
In the current study, we identified additional members of the ILP family previously 
characterized by Soares et al. (25) and Ribeiro et al.(20).  All family members identified 
except Salp9 possess putative secretion signals, contain 4 conserved cysteines in the mature 
protein, and retain at least four of the seven N-linked glycosylation sites.  An individual tick 
may express many or all of these genes, with expression patterns that change over time or in 
different tissues.  Alternatively, proteins encoded by genes of this family with potentially 
similar functions within an individual tick may display antigenic variation, which may be 
needed to escape host immune responses during prolonged feeding periods.  However, since 
the family members were isolated from cDNA libraries generated from hundreds of nymphal 
ticks, variation in the sequences may be a result of genetic variation between individual ticks, 
rather than each tick possessing several family members.   
 In this work, we also successfully produced and purified Salp20 from E. coli and 
High Five insect cells.  Only the protein produced in insect cells had functional activity.  
Furthermore, the insect expressed protein had an approximate molecular weight of 48 kDa, 
unlike the expected molecular weight of 24 kDa.  N- and O-linked glycosylations were 
primarily responsible for the increased molecular mass.   S20NS may contain other post-
translational modifications since removal of all carbohydrates shifted the protein to 
approximately 30 kDa, rather than 24 kDa.  Interestingly, other members of this salivary 
protein family also appear to have increased masses as Isac was approximately 45 kDa, even 
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though the predicted size was only 18.5 kDa (29) and additional family members identified 
in this study have larger masses than predicted when expressed in High Five cells (data not 
shown). 
 We found S20NS inhibited the alternative pathway of complement but not the 
classical pathway.  The protein inhibited the alternative pathway by preventing the cleavage 
of C3 into C3a and C3b, thereby preventing the deposition of C3b onto RbE surfaces.  
Further investigation demonstrated S20NS dissociated fB from covalently bound C3b, 
disrupting the C3 convertase.  This mechanism of inhibition is similar to fH and the 
mechanism previously demonstrated for Isac (28). 
Inhibition of the alternative pathway by a family of I. scapularis complement 
inhibitors including both Isac and Salp20 potentially allows successful feeding of the tick by 
limiting the production of an inflammatory response at the site of tick feeding.  In fact, 
Soares et al. (25) reported that RNAi mediated silencing of Salp20 in ticks interfered with 
successful tick feeding.  In addition to allowing for successful tick feeding, inhibition of the 
alternative complement cascade by I. scapularis salivary proteins may also allow successful 
pathogen transmission from an infected tick.  Ramamoorthi et al. (18) have demonstrated 
Salp15, an I. scapularis salivary protein, binds B. burgdorferi surfaces and significantly 
enhances its transmission to a host during tick feeding.  In this work, we have demonstrated 
that serum sensitive species of Borrelia survive killing by human complement components in 
the presence of recombinant Salp20, indicating this family of proteins potentially facilitates 
efficient pathogen transmission during tick feeding.     
At this time, we are interested in determining the importance and necessity of the 
large family of salivary proteins that possibly inhibit host complement.  We are currently 
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investigating whether other family members block the alternative complement pathway in a 
manner similar to both Isac and Salp20.  Furthermore, we are interested in determining if any 
of these family members display antigenic variation or posses other activities that may be 
essential for successful tick feeding and/or pathogen transmission.   
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Figure 2.1 Amino acid alignment of Salp20, Isac, and cDNA clones related to both Salp20 
and Isac. Clones identified by PCR analysis from whole tick and salivary gland cDNA 
libraries were aligned with Salp20, Isac, and cDNA clones previously identified by Soares et 
al. (25).  Boxed light gray residues indicate conserved amino acids in all clones, and dark 
gray boxed residues indicate conservation among some of the clones.  The putative secretion 
signals of Salp20, Isac, and all cDNA clones are boxed.  Potential N-linked glycosylation 
sites are marked by arrows and cysteines conserved in the mature proteins of all clones are 
indicated asterisks.       
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Figure 2.2 Expression of Salp20 in High Five (Trichoplusia ni) cells.  Western blot analysis 
of either media or cell lysates from cultures of High Five cells stably transfected with pIB-
CAT (CAT) (~ 34 kDa), pIB-S20NS (S20NS) (~ 48 kDa).  Blots were probed with mouse α-
V5 IgG (1:5000), washed, and subsequently probed with AP-conjugated goat α-mouse IgG 
(1:1000).  
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Figure 2.3 Purification of S20NS from transfected High Five cell media.  Media from 
transfected High five cells was dialyzed and then subjected to immobilized metal affinity 
chromatography.  Fractions were collected and subjected to SDS-PAGE analysis followed by 
Simply Blue Staining.  F.T. – flow through, W1 – wash 1, E1 – elution 1.    
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Figure 2.4 Deglycosylations and lectin blotting of S20NS.  For deglycosylations, S20NS was 
either digested with PNGase F overnight at 37oC or treated with TFMS for 3 hrs at 4oC.  The 
glycosylated and deglycosylated proteins were subjected to 10% SDS-PAGE and Western 
blot analysis with a monoclonal mouse anti-V5 antibody (1:5000) (A) or lectin blot analysis 
with DIG-labeled GNA (1:1000) and AP-conjugated anti-DIG sheep Fab fragments (1:1000) 
(B).   
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Figure 2.5 RbE Lysis Assays with I. scapularis saliva (A) or S20NS (B).  Various amounts 
of tick saliva (A) or various concentrations of S20NS or a negative control protein, 
glutathione-S-transferase (GST), (B) were incubated with RbEs and NHS (1:4) in the 
presence of Mg2+ for 30 min at 37oC.  The O.D. of supernatants from pelleted cells after lysis 
had occurred was measured and the percent lysis was calculated.  The RbE lysis assay with 
S20NS (B) is a representative experiment of 10 different experiments giving similar results.  
The error bars for each assay depict the standard deviation of the mean O.D. value of 
triplicates.   
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Figure 2.6 Activation of C3 and deposition of C3b on RbE surfaces during RbE lysis assays 
using C5 depleted human serum.  (A) Supernatants from RbE lysis assays using C5-/- human 
serum were collected and subjected to Western blot analysis with rabbit α-human C3a 
antibody (1:1000) and AP-conjugated goat α-rabbit IgG (1:1000).  C3a (10 kDa), C3 α-
chains (~ 110 kDa), iC3(H2O ) α-chains (~ 77 kDa), and C3 α-chain degradation products (~ 
45 kDa) are all indicated by the arrows.  (B) Pellets from the lysis assays were collected, 
washed, resuspended, and subjected to Western blot analysis using goat α-human C3 
antibody (1:1000) and AP-conjugated rabbit α-goat IgG (1:25000). Covalently attached C3 
α-chains (α`), C3 β-chains (~ 76 kDa), and α-chain degradation products (~ 45 kDa) are 
indicated by the arrows.  As a positive control for activation of the alternative pathway and 
lysis of the RbEs, NHS was used instead of C5-/- human serum in both (A) and (B). 
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Figure 2.7 Deposition of human C3 (A) or Factor B (B) in the presence of recombinant 
S20NS.  NHS (1:4) in AP Buffer was added to agarose coated wells and either S20NS or 
CAT (10 µg/ml) were added to the wells of a 96-well plate either immediately with NHS (0 
min) or 30 min after NHS (30 min).  (A) Plates were washed and incubated with a primary 
goat α-human C3 antibody (1:1000) and a secondary rabbit α-goat AP conjugated antibody 
(1:1000).  (B) Plates were washed and incubated with a primary goat α-human fB antibody 
(1:5000) and a secondary rabbit α-goat IgG AP conjugated antibody (1:1000).  Each graph 
depicts a single experiment performed in triplicate that is representative of 4 experiments 
with similar results.  The error bars represent the standard deviation of the mean O.D value.  
The asterisks represent statistically significant differences between negative controls (0 
µg/ml) and S20NS samples (10 µg/ml) at each timepoint where p<0.05. 
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Figure 2.8 Borreliacidal assays in the presence of S20NS.  B. burgdorferi (serum resistant) 
or B. garinii (serum sensitive) at a density of 1 x 107 cells/ml were incubated with 20% NHS 
for 1 hour at 33oC in the absence or presence of 10 µg/ml of S20NS or CAT.  As a negative 
control for killing, cells were also incubated with 20% heat inactivated NHS (HI NHS).  
After incubation, live cells were counted by dark field microscopy and cell densities were 
determined.  The lower detection limit of the assay was 5 x 104 cells/ml.  The results depict a 
single experiment performed in duplicate that represents 3 experiments with similar results.  
The error bars represent the standard deviation of the mean cell density.  The asterisk 
represents statistically significant difference between the NHS and S20NS+NHS groups 
where p<0.06.
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3.1 Abstract 
Ixodes scapularis Salp20 is a member of the ILP family that inhibits the alternative 
complement pathway.  In this study, we demonstrate that the target of Salp20 is properdin.  
Properdin is a natural, positive regulator of the alternative pathway that binds to the C3 
convertase, stabilizing the molecule. Salp20 directly bound to and displaced properdin from 
the C3 convertase.  Displacement of properdin accelerated the decay of the C3 convertase, 
leading to inhibition of the alternative pathway.   S20NS is distinct from known decay 
accelerating factors, such as DAF, CR1, and fH, which directly interact with either C3b or 
Bb.  
 
3.2 Introduction
Ixodes ticks are efficient vectors of various pathogens, including B. burgdorferi, the 
causative agent of Lyme disease (1, 2).  Tick saliva contains multiple proteins that modulate 
host immunity and hemostasis, which facilitate blood feeding and pathogen transmission (3).  
One property of tick saliva is inhibition of the alternative complement pathway (4-6).  Isac, 
Salp20, Irac-1, and Irac-2 are members of a large family of homologous proteins, referred to 
as the ILP family, that specifically inhibit the alternative pathway by dissociating the 
components of the C3 convertase, C3b and Bb (7-11).  While preventing the activation of the 
alternative pathway, Salp20 also protects B. garinii from complement mediated killing by 
NHS (10), suggesting these anti-complement proteins facilitate tick feeding as well as 
pathogen transmission and survival.  
 In this work, we have characterized the specific mechanism by which Salp20 inhibits 
the alternative pathway.  We demonstrate that Salp20 directly binds to properdin, a positive 
regulator of the alternative pathway.  Salp20 displaces properdin from the C3 convertase, 
thus accelerating the decay of the alternative pathway C3 convertase.   
 
3.3 Materials and Methods 
Recombinant proteins, purified proteins, and antibodies 
 S20NS and CAT were expressed and purified from stably transfected High Five cells 
as described previously (10).  Recombinant protein purity was determined by SDS-PAGE, 
while purified protein concentrations were determined by Bradford analysis.  Purified human 
complement components – C3b (cat no. A114), fB (cat no. A135), fD (cat no. A136), and 
properdin (cat no. A139) – and antibodies directed against the complement components – 
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goat α-human C3 (cat no. A213), goat α-human fB (cat no. A235), and goat α-human 
properdin (cat no. A239) were obtained from CompTech (Tyler, TX).  Mouse α-His IgG was 
obtained from Qiagen and mouse α-V5 IgG was obtained from Invitrogen (Carlsbad, CA).       
Assays to measure the decay of C3 convertases  
To measure the decay of C3 convertases formed from complement components in NHS  in 
the presence of S20NS, ELISAs were performed as described previously (9, 10).  Briefly, 
microtiter plates were coated with 0.1% agarose for 48 h at 37oC.  To form C3 convertases in 
the wells, the agarose coated wells were then incubated with NHS in AP Buffer (gelatin 
veronal buffer with Mg2+ and Ca2+ [GVB++, CompTech, Tyler, TX], 5 mM EGTA, 5 mM 
MgCl2) for 1 h at 37oC.  The plate bound convertases were subsequently washed and 
incubated with various concentrations of S20NS for 30 min at 37oC.  After incubation, the 
wells were washed with Wash buffer (TBS, 10 mg/ml BSA, 2 mM MgCl2), and any 
remaining plate-bound Bb or properdin were detected by standard ELISA methods using 
either a primary goat α-human fB Ab or a goat α-human properdin Ab, followed by a 
secondary AP-conjugated rabbit α-goat IgG.  OD405 values were determined and percent 
deposition was calculated using the following equation: ((OD405 sample – OD405 NHS with 
25mM EDTA)/(OD405 sample without S20NS or CAT – OD405 NHS with 25mM EDTA)) x 
100. 
To measure the decay of C3 convertases formed from purified components in the 
presence of S20NS, we performed an ELISA adapted from Hourcade et al. (12).  Microtiter 
plate wells were coated with 250 ng/well of C3b in PBS for 12 h at 4oC.  After coating, the 
wells were washed with PBS and then blocked for 15 min at 23oC with Binding buffer (PBS, 
75 mM NaCl, 5mM NiCl2, 4% BSA, 0.05% Tween-20).  To form the C3 convertase, fB (400 
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ng/well) and fD (25 ng/well) in Binding buffer were added to the wells and incubated at 37oC 
for 2 h.  The wells were subsequently washed with PBS and then incubated with various 
concentrations of S20NS, CAT, or fH in Binding buffer for 30 min at 37oC.  The wells were 
washed with TBST (TBS, 0.2% Tween-20), and the OD405 was determined for any remaining 
Bb by ELISA using specific antibodies.  Percent deposition was calculated using the 
following equation: ((OD405 sample – OD405 C3b coated wells)/(OD405 sample without 
S20NS or CAT – OD405 C3b coated wells)) x 100. 
In some assays, properdin was included in the formation of the C3 convertase from 
purified complement components.  After coating the wells with C3b, fB (50 ng/well), fD (25 
ng/well), and properdin (50 ng/well) in Mg2+ Binding buffer (PBS, 75 mM NaCl, 10 mM 
MgCl2, 4% BSA, 0.05% Tween) were incubated in the wells for 2 h at 37oC.  Plate bound Bb 
and properdin were detected by standard ELISAs.  In these assays, the concentration of fB 
was lower than in the assays lacking properdin because properdin stabilized the C3 
convertase more efficiently than the substitution of Mg2+ with Ni2+ in the assays lacking 
properdin.  Since the convertase was stabilized more efficiently, less fB was needed to 
achieve equivalent OD405 readings for fB deposition between the two assays.  Percent 
deposition was calculated as described above.  To form C3b-properdin (C3bP) complexes, 
plates were coated with C3b as described above and properdin (50 ng/well) was subsequently 
added.  Bound properdin was detected as described.   
Cofactor activity assays  
 To investigate the cofactor activity of S20NS during fI mediated degradation of C3b, 
cofactor activity assays were performed following a modified protocol of McRae et al. (13).  
Briefly, 200 ng of C3b was incubated with various concentrations of S20NS, fH, or CAT and 
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400 ng of fI in reaction buffer (10 mM Tris-Cl pH 7.5, 150 mM NaCl) for 30 min at 37oC.  
After incubation, C3b degradation products were analyzed by immunoblots using a primary 
goat α-C3 Ab and a secondary AP-conjugated rabbit α-goat IgG.  
To determine if S20NS degraded C3b in the presence of fH, 200 ng of C3b were 
incubated with 400 ng of either S20NS or fI and 1 µg of fH in reaction buffer for 30 min at 
37oC.  C3b degradation products were then detected by immunoblotting. 
Assays to detect Salp20 binding to properdin 
 To detect direct binding of S20NS to properdin, we performed immunoprecipitations 
and analyzed the precipitates by immunoblot.  S20NS (150 ng) was incubated with properdin 
(450 ng) at 37oC for 30 min in Binding buffer (PBS, 75 mM NaCl, 10 mM MgCl2, 0.05% 
Tween) and then added to blocked Protein-A sephadex beads (Sigma, St. Louis, MO) coated 
with 1 µg of mouse α-V5 IgG for 1 hour at 37oC.  The sephadex beads were washed and 
resuspended in non-reducing SDS-PAGE loading dye.  Samples were subjected to SDS-
PAGE and immunoblotting with antibodies specific for either S20NS or properdin. 
As an alternative method to detect S20NS binding to properdin, microtiter plate wells 
were first coated with 100 ng/well of S20NS, CAT, or C3b for 12 h at 4oC.  The wells were 
then blocked and incubated with 100 ng/well properdin for 1 h at 37oC.  After incubation, the 
wells were washed.  To detect plate bound properdin, the wells were incubated with a 
primary goat α-properdin Ab and a secondary AP-conjugated rabbit α-goat IgG.  
Saturation Binding Assays 
  To determine the relative binding affinity of properdin for either S20NS or C3b, we 
performed a solid-phase binding assay.  Microtiter plates were coated with a saturating 
amount of either S20NS (10 ng/well) or C3b (10 ng/well) for 12 hrs at 4oC in 0.1M 
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Carbonate Binding Buffer, pH 9.2.  After coating, the wells were blocked with Binding 
buffer for 1 hr at 37oC and then incubated with increasing concentrations of properdin in 
Binding buffer (PBS, 75 mM NaCl, 10 mM MgCl2, 0.05% Tween) at 37oC for 1 hr  The 
wells were then washed with TBST, and bound properdin was detected by an ELISA using a 
primary goat α-human properdin Ab and a secondary AP-conjugated rabbit α-goat Ab.  
Development of the substrate was stopped after 3 min by the addition of 3M NaOH.  The 
OD405 was determined and plotted, and relative Kd values were calculated using GraphPad 
Prism 4 (GraphPad Software).          
 
3.4 Results  
S20NS specifically inhibits the alternative complement pathway by dissociating the C3 
convertase   
 Isac and related tick salivary proteins, including S20NS, specifically inhibit the 
alternative complement pathway by dissociating the components of the C3 convertase (5, 9-
11).  In the current study, the mechanism of inhibition of the alternative pathway by S20NS 
was confirmed by performing an agarose based ELISA as described previously (9).  In this 
assay, C3 present in NHS is activated by agarose coated microtiter plates.  C3 activation 
leads to the formation of an active convertase on the agarose consisting of covalently bound 
C3b and Bb (9).  When increasing concentrations of S20NS were incubated with preformed 
covalently bound C3 convertases, the amount of bound Bb was reduced (IC50 of S20NS = 0.8 
µg/ml) (Fig 3.1).  Equal concentrations of purified recombinant CAT protein, a negative 
control protein expressed from the same expression vector as S20NS in High Five cells, did 
not disrupt the C3 convertase. Previous studies have demonstrated that covalently attached 
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C3b is unaffected in the presence of S20NS (10).  Together, these results indicate that S20NS 
inhibits the alternative complement pathway by specifically dissociating Bb from the C3 
convertase, similar to the activity of Isac and related family members (9-11).  Since the IC50 
of S20NS = 0.8 µg/ml, we chose to use concentrations of either 1 or 2 µg/ml of S20NS for 
subsequent experiments.       
S20NS is a unique regulator of the alternative pathway  
Since S20NS and Isac inhibit the alternative pathway by dissociating Bb from the C3 
convertase, it has been hypothesized that Salp20 and Isac act in a manner similar to fH, a 
natural negative regulator of the alternative pathway (9).  Human fH is a serum glycoprotein 
that directly binds C3b, displacing Bb and causing decay acceleration of the C3 convertase 
(14, 15).  In addition, fH also acts as a cofactor for fI mediated degradation of C3b (14, 16, 
17).  To determine if S20NS acted by the same mechanism as fH, we performed ELISAs to 
measure the decay of C3 convertases in the presence of S20NS or fH.  In these assays, we 
formed C3 convertases in the wells of microtiter plates from purified complement 
components (C3b, fB, and fD) and then incubated S20NS or various control proteins with the 
convertases.  After the incubation, we detected any remaining bound Bb in the convertases 
by ELISA.  The C3 convertases formed from purified components were disrupted by fH as 
indicated by the reduction in the amount of deposited Bb (Fig 3.2A).  Surprisingly, however, 
S20NS displayed no effect (Fig 3.2A).  These results indicate that in this assay S20NS does 
not share similar activity to fH.  Moreover, these results also demonstrate that S20NS 
dissociates C3 convertases formed from NHS (Fig 3.1) but not convertases formed from 
purified complement components (Fig 3.2A). 
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Experiments were also performed to determine if S20NS acted as a cofactor for fI 
mediated degradation of C3b, similar to fH.  S20NS was mixed with purified fI and the 
mixture was then added to purified C3b.  Degradation products of the C3b α-chain (C3b α`-
chain), 67 and 43 kDa fragments, were detected by immunoblots with specific Abs.  Various 
concentrations of either S20NS or CAT were incapable of mediating fI degradation of C3b, 
unlike fH, which when incubated in the presence of fI, resulted in the degradation of C3b 
(Fig 3.2B).   
Since S20NS did not act as a cofactor for fI mediated C3b degradation like fH, 
experiments were done to test if S20NS functioned similarly to fI and degraded C3b in the 
presence of fH.  When S20NS was mixed with fH and then incubated with C3b, we observed 
no degradation of C3b, whereas fI incubated with fH and C3b resulted in C3b degradation 
(Fig 3.2C).  Together, these results demonstrate that S20NS disrupts the C3 convertase by a 
mechanism that is different from both fH and fI.                      
S20NS inhibits the alternative pathway by displacing properdin from the C3 convertase 
 S20NS dissociated the components of the C3 convertase when the convertase was 
formed from NHS (Fig 3.1) but not from purified complement components (Fig 3.2A).  The 
discrepancy in the activity of S20NS between the two assays is likely due to differences in 
the composition of the convertases formed from either NHS, which potentially contain C3b, 
Bb, and properdin, or from purified complement components, which contain only C3b and 
Bb.  Properdin is a positive regulator of the alternative pathway that binds and stabilizes the 
C3 convertase, significantly increasing its half life (18, 19). To determine if the inhibitory 
activity of S20NS was potentially mediated through properdin, we formed C3 convertases 
from purified complement components in the presence of properdin and then incubated 
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S20NS or control proteins with the convertases.  When S20NS was incubated with C3 
convertases containing properdin, approximately 90% of Bb was displaced (Fig 3.3), in 
contrast to its effect on convertases lacking properdin (Fig 3.2A).  Factor H displaced Bb 
from C3 convertases formed in either the presence or absence of properdin (Fig 3.2A and Fig 
3.3).   
After establishing that S20NS was only active against convertases containing 
properdin, experiments were done to determine if S20NS displaced properdin from the C3 
convertase.  S20NS displaced properdin from C3 convertases formed from purified 
components (Fig 3.4A) as well as from convertases formed from NHS (Fig 3.4B).  In 
addition, S20NS also displaced properdin from complexes containing only C3bP, 
demonstrating the specificity of S20NS for properdin (Fig 3.4C).  Unlike S20NS, fH did not 
displace properdin from C3 convertases (Fig 3.4A) or from C3bP complexes (Fig 3.4C). 
Together, these results demonstrate that S20NS uniquely accelerates the decay of C3 
convertases by specifically displacing properdin from the convertase. 
S20NS binds properdin 
To determine if S20NS directly interacted with properdin to dissociate the C3 
convertase, S20NS and properdin were incubated together and S20NS was next 
immunoprecipitated using an antibody that bound to its C-terminal V5-epitope tag.  The 
precipitates were then immunoblotted for either S20NS or properdin with specific Abs.  In 
the immunoblots, we detected S20NS as well as properdin in the precipitates (Figure 3.5A), 
indicating that S20NS directly bound to properdin.   
The interaction between Salp20 and properdin was also confirmed by ELISA.  
Microtiter plate wells were coated with S20NS and then incubated with properdin.  After 
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incubation, bound properdin was detected with specific Abs.  In wells coated with either 
S20NS or C3b, we detected specific binding of properdin when compared to the negative 
control, CAT (Fig 3.5B). 
In addition to studying the direct interaction between S20NS and properdin, we also 
calculated the relative binding affinity of properdin for either S20NS or C3b by performing 
solid-phase saturation binding assays.  In these assays, microtiter plates were coated with 
equal amounts of either S20NS or C3b.  Increasing concentrations of properdin were then 
added to the wells, and bound properdin was detected with specific antibodies.  Properdin 
binding to S20NS saturated at a lower concentration than properdin binding to C3b (Fig 
3.5C).  The relative Kd of properdin binding to S20NS = 0.669 nM where the relative Kd of 
properdin binding to C3b > 85 nM.  These results indicate properdin binds to S20NS with an 
affinity that is >100 fold higher than its affinity for C3b.        
 
3.5 Discussion 
In this study, we have demonstrated that S20NS is only active against C3 convertases 
containing properdin.  The simplest mechanism consistent with our data is that S20NS 
directly interacts with properdin, causing its dissociation from the C3 convertase and the 
subsequent decay acceleration of the convertase.  This model is supported by the 
observations that 1) properdin directly bound to Salp20 with a relative affinity that was at 
least 100 fold higher than the affinity of properdin for C3b and 2) Salp20 treatment reduced 
the levels of properdin on preformed C3 convertases and C3bP complexes.   We cannot 
completely rule out alternative models such as properdin facilitating necessary contacts 
between Salp20 and C3bBb, allowing S20NS to bind the convertase directly and cause decay 
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acceleration.  However, as we have not found any S20NS physically associated with the 
inactivated convertase (data not shown), we favor the model in which Salp20 acts by directly 
displacing properdin from the convertase.   
All of our studies were performed with insect cell expressed recombinant S20NS, 
which we believe functions almost identically to native Salp20 expressed in tick saliva.  
Valenzuela et al. have demonstrated that native Isac, purified directly from tick salivary 
gland extracts, inhibited the alternative complement pathway, likely by dissociating the C3 
convertase (9).  This result supports the idea that the activity S20NS closely mimics the 
activity of native Salp20.   
Our proposed model for S20NS mediated displacement of properdin from the C3 
convertase is consistent with the previous studies (5).  Lawrie et al. determined that I. ricinus 
salivary gland extracts (SGE) inhibited the activity of C3 convertases formed from NHS on 
erythrocyte surfaces, but had no effect on C3 convertases formed from purified complement 
components.  In addition, when cobra venom factor (CVF) was used as an activator of 
complement in the presence of NHS, I. ricinus SGE displayed no inhibitory activity against 
the CVFBb convertase.  Since properdin was absent in the pure component and CVF assays, 
these negative results could be explained by our model where the active inhibitory 
component in tick SGE, in particular, S20NS or related ILP family members, acts through 
properdin.    
The decay accelerating activity of S20NS is unique and distinct from any of the 
characterized alternative pathway decay accelerating factors, DAF, CR1, and fH, which 
directly interact with C3bBb or C3b to destabilize the C3 convertase (15, 20-25).  S20NS 
displaced properdin from C3 convertases and C3bP complexes, whereas fH did not displace 
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properdin in our assays. In a previous study, Hourcade used surface plasmon resonance to 
demonstrate that fH binding to C3 convertases results in the decay of C3 convertases and the 
dissociation of properdin (18).  We may not have observed properdin dissociation following 
fH treatment because C3 complexes formed in our ELISAs differ from the convertases 
formed in the surface plasmon resonance study.  Specifically, the C3 convertase complexes 
formed in our assays are likely to contain both complete C3 convertases and C3bP 
complexes.  The properdin displaced by S20NS in our assays might be mainly derived from 
C3bP complexes, which are not affected by fH.   
Even though properdin is not an active component of the C3 convertase, it is essential 
for the stabilization and full activity of the convertase (19, 26).  Gupta-Bansal et al. and 
Perdikoulis et al. have demonstrated that Abs directed against properdin are capable of 
inhibiting the alternative pathway (26, 27).  Recent studies have also shown that properdin is 
capable of binding to cell surfaces and initiating the alternative pathway by providing a 
platform for the assembly of the C3 convertase (28).  Since properdin is vital for effective 
complement activation, it is an attractive target for inactivation by pathogens or blood 
feeding organisms.  One example of a virulence factor that targets properdin is streptococcal 
pyrogenic exotoxin B, which acts to degrade properdin, allowing the pathogenic group A 
streptococci to resist opsonophagocytosis mediated by complement (29).    
Salp20 is a member of the ILP family, containing at least 49 members (7, 8, 10, 11).  
In addition to Salp20, several members of this family, specifically Isac, Irac-1, Irac-2, 
S20Lclone 12, and S20Lclone 2, inhibit the alternative pathway by decay acceleration of the 
C3 convertase (9-11) (data not shown).  It is likely that these proteins also interact with 
properdin.   
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Properdin is composed of short N- and C-terminal regions separated by  6 TSRs (30), 
which make up the majority of the protein. We propose that Salp20 and other ILP family 
members specifically bind the TSRs of properdin to cause its displacement from the C3 
convertase.  The TSRs found in properdin and several other proteins primarily bind sulfated 
glycoconjugates and glycosaminoglycans (GAGs) (31, 32).  Interestingly, S20NS contains 
multiple N- and O-linked glycans that make up almost half the molecular weight of the 
mature protein (10).  These carbohydrate modifications may potentially be sulfated 
glycoconjugates and GAGs, allowing S20NS to resemble the sulfated glycoconjugates and 
bind the TSRs of properdin.   
In addition to properdin, TSRs are found in other complement proteins, cell adhesion 
molecules, and proteases, many of which regulate host hemostasis and innate immunity (33).  
In addition to their roles in complement inhibition, we speculate different ILP family 
members may target different TSR containing proteins to alter host hemostasis and innate 
immunity, facilitating tick feeding.  ILP family members may prove to be useful for 
developing anti-tick vaccines as well as novel therapies for complement mediated diseases. 
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 Figure 3.1 S20NS inhibits the alternative complement pathway by dissociating the C3 
convertase.  C3 convertases were preformed on agarose surfaces from complement 
components in NHS.  Ten-fold dilutions of S20NS or CAT were then added to the preformed 
convertases and the amount of remaining Bb was determined by ELISA.  The error bars 
represent 2 standard deviations from the mean where N=6. 
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 Figure 3.2 S20NS does not dissociate the C3 convertase by a mechanism similar to fH or fI.  
A, C3 convertases were preformed in microtiter plate wells from purified complement 
components (C3b, fB, and fD) and washed.  S20NS (1 µg/ml), fH (1 µg/ml), CAT (1 µg/ml, 
negative control), or buffer alone (0 µg/ml) were then added to the preformed convertases 
and the amount of remaining bound Bb was determined by ELISA.  The error bars represent 
2 standard deviations from the mean where N=6.  The asterisk indicates statistical 
significance (p=0.008) between the 0 µg/ml and 1 µg/ml samples of fH as measured by a 
student t-test.  B, Various concentrations of S20NS or fH were incubated with C3b in the 
presence of fI, and C3b degradation products, represented by the 67 and 43 kDa bands, were 
visualized by Western blots using a polyclonal goat α-hC3 Ab.  C, S20NS or fI were 
incubated with C3b in the presence of fH.  C3b degradation products were visualized by 
Western blots as described in Fig 2B. M, marker.        
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 Figure 3.3 S20NS dissociates the C3 convertase only in the presence of properdin.  C3 
convertases were formed from purified components (C3b, fB, and fD) in the presence of 
properdin and then washed.  S20NS (1 µg/ml), fH (1 µg/ml), or buffer (0 µg/ml) were added 
to the preformed convertases and the amount of remaining bound Bb was determined by 
ELISA.  The error bars represent 2 standard deviations from the mean where N=6.  The 
asterisks indicate statistical significance between the 0 µg/ml and 1 µg/ml samples as 
measured by a student’s t-test where p<0.001. 
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 Figure 3.4  S20NS dissociates properdin from the C3 convertase.  A, C3 convertases were 
formed from purified complement components as described in Fig 3.  S20NS (2 µg/ml), fH 
(2 µg/ml) or buffer (0 µg/ml) were then incubated with the preformed convertases, and 
bound properdin was detected by ELISA.  B, C3 convertases were formed from complement 
components in NHS as described in Fig 1.  S20NS (2 µg/ml), CAT (2 µg/ml, negative 
control), or buffer (0 µg/ml) were then incubated with the preformed convertases and bound 
properdin was detected by ELISA.  C, C3bP complexes were formed from purified C3b and 
properdin.  S20NS (2 µg/ml), fH (2 µg/ml) or buffer (0 µg/ml) were then incubated with the 
complexes, and bound properdin was detected by ELISA.  The error bars represent 2 
standard deviations from the mean where N=6.  The asterisks indicate statistical significance 
between the 0 µg/ml and 2 µg/ml samples of S20NS as measured by a student’s t-test where 
p<0.001. 
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 Figure 3.5  S20NS binds properdin.  A, S20NS (S), properdin (P), or S20NS previously 
incubated with properdin (S+P) were immunoprecipitated (IP) with a monoclonal α-V5 Ab 
against an epitope tag on S20NS.  Immunoprecipitates were then analyzed by Western Blots 
using specific Abs directed against properdin (α-fP) or S20NS (α-His).  B, Microtiter plate 
wells were coated with S20NS, CAT (negative control), or C3b (positive control).  The wells 
were washed, blocked, and then incubated with properdin.  Bound properdin was detected by 
ELISA.  The error bars represent 2 standard deviations from the mean where N=6.  C, 
Microtiter plate wells were coated with either S20NS or C3b.  Increasing concentrations of 
properdin were then added to the wells, and bound properdin was detected by ELISA.  The 
data depict a single experiment performed in triplicate that is representative of 3 independent 
experiments.  The error bars represent the standard error from the mean.
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4.1 Abstract 
 I. scapularis ticks secrete numerous anti-hemostatic, anti-inflammatory, and 
immunosuppressive proteins during feeding.  Isac and Salp20, two I. scapularis salivary 
anti-complement proteins, are members of a large family of paralogous tick proteins 
designated the ILP family.  Salp20 specifically binds properdin, resulting in C3 
convertase destabilization.  In this study, we examined the functions of two ILP family 
members, S20Lclone 12 and S20Lclone 2, which share 95% and 67% amino acid identity 
with Salp20, respectively.  Recombinant S20Lclone 12 (S20L12) and S20Lclone 2 
(S20L2) inhibited the alternative complement pathway by specifically binding properdin 
with similar affinities, identical to Salp20.  When mixed together, recombinant Salp20 
 
(S20NS), S20L12 and S20L2 displayed no synergistic inhibitory effects beyond the activity 
of the individual proteins.  Furthermore, S20NS, S20L12, S20L2 similarly inhibited the 
alternative complement pathway of various host animals, indicating different ILP family 
members do not display host specificity.  Finally, we determined that S20NS, S20L12, and 
S20L2 specifically interacted with properdin and no other TSR-containing proteins. 
 
4.2 Introduction 
 I. scapularis, commonly known as the blacklegged tick, is an exclusively blood 
sucking ectoparasite that feeds on a host for several days to weeks (28).  In order to avoid 
host recognition and rejection, I. scapularis ticks secrete numerous pharmacologically active 
components in their saliva during feeding, which block host hemostasis, inflammation, and 
immune recognition (3, 4, 16, 24, 33, 38).  Recently, multiple groups have determined that 
many of the anti-hemostatic, anti-inflammatory, and immunosuppressive components in 
ixodid tick saliva, including I. scapularis saliva, are members of large families of related 
proteins (7, 10, 12, 17, 19, 23, 27, 35).  Daix et al. demonstrated that I. ricinus anti-
complement proteins, Irac-1 and Irac-2, are both expressed within the salivary glands of an 
individual tick, indicating that multiple members of different tick salivary protein families 
are likely co-expressed within individual feeding ticks (7).  
 Salp20 is an anti-complement protein secreted in I. scapularis saliva that inhibits the 
alternative complement pathway by directly binding properdin, which causes decay 
acceleration of the C3 convertase (32) (Chapter 3).  Salp20 and its homologue, Isac, are both 
members of the ILP family of anti-complement salivary proteins.  Currently, the ILP family 
is comprised of approximately 49 unique members, sharing between 64% and 95% amino 
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acid identity to either Isac or Salp20 (23, 27, 32).  At this time, only Salp20 and Isac have 
been demonstrated to be complement inhibitors and the functions of other ILP family 
members are unknown.   
 In addition to the anti-complement ILP family members identified in I. scapularis, 
Daix et al. and Couvreur et al. have also identified multiple I. ricinus proteins that share 
homology with Isac and Salp20 (6, 7).  Recombinant Irac-1 and Irac-2, two I. ricinus Isac 
homologues, were found to inhibit the alternative complement pathway by preventing C3 
convertase assembly and by dissociating Bb from C3b in the C3 convertase, similar to Isac 
and Salp20 (7).  This evidence further supports the idea that related ILP family members 
likely share functional similarities.    
 Two I. scapularis ILP family members that were identified in the studies described in 
Chapter 1, S20Lclone 12 and S20Lclone 2, share approximately 95% and 67% amino acid 
identity with Salp20, respectively.  In this chapter, we express recombinant S20Lclone 12 
and S20Lclone 2 and examine their functions in relation to S20NS.  We also attempt to 
characterize any differences that may exist between S20Lclone 12, S20Lclone 2, and S20NS 
in an effort to understand why ticks produce so many different proteins that are closely 
related. 
 
4.3 Materials and Methods 
Cell lines and media 
 Adherent cultures of High Five cells (Invitrogen, Carlsbad, CA), derived from the 
cabbage looper, Trichoplusia ni, were seeded and maintained according to the instructions of 
the manufacturer.  The cells were grown in Express Five Serum free media (SFM) (Gibco, 
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Carlsbad, CA) supplemented with L-glutamine (18 mM) (Gibco, Carlsbad, CA), penicillin 
(100 U/ml), streptomycin (100 µg/ml), and fungizone (0.25 µg/ml) (Gibco, Carlsbad, CA) at 
28oC.   
Expression and purification of S20Lclone 12 and S20Lclone 2 in High Five cells  
 To express recombinant S20Lclone 12 and S20Lclone 2 in High Five cells, we used 
an approach similar to Alarcon-Chaidez et al. (2).  S20Lclone 12 was first PCR amplified 
from the pCR 2.1 TOPO vector using the following primers: KS20F – 5` 
CCAGCCATGAGGACTGCGCT 3` and S20RNS – 5` 
GGAAATTGCCTCGAATGAGTCTC 3`, while S20Lclone 2 was amplified using the 
following primers: SLC13F – 5` GCTCAGTTATGAGGACTGTGCTG 3` and SLC13RNS – 
5` GGGGACGGCCACAGGCTCAA 3`.  The 5` primers contained Kozak sequences to 
allow for efficient protein expression from the cloning vector, while the 3` primers lacked 
stop codons to allow the fusion of a V5-epitope and 6X-His tag to the C-terminus of the 
proteins.  Once amplified, the PCR products were cloned into the expression vector pIB/V5-
His-TOPO (Invitrogen), which contains both ampicillin and blasticidin resistance genes 
allowing for selection in E. coli and High Five cells, generating the constructs pIB-
S20Lclone 12 and pIB-S20Lclone 2.  Constitutive expression of S20Lclone12-V5-His 
(S20L12) and S20Lclone 2-V5-His (S20L2) was controlled by the Orgyia pseudotsugata 
baculovirus promoter, OpIE2.  The resulting constructs, pIB-S20L12 and pIB-S20L2, were 
purified using the QIAfilter Plasmid Midi Kit (Qiagen, Valencia, CA) and transfected into 
High Five cells following the manufacturer’s protocol.  As a positive control for protein 
expression and purification, High Five cells were also transfected with pIB-CAT (Invitrogen, 
Carlsbad, CA), the pIB/V5-His vector containing chloramphenicol acetyltransferase (CAT).  
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Stably transfected cells were selected and maintained by the addition of blasticidin (10 
µg/ml) to the cell culture media. 
 For protein purification, adherent cultures of stably transfected cells were grown to 
90% confluency in T-175 flasks.  Cells were then collected and seeded into 500 ml of culture 
media in 3L Fernbach flasks (Corning, Corning, NY) at a density of 5 x 105 cells/ml.  
Cultures were grown at 28oC with gentle agitation until reaching a density of 2-3 x 106 
cells/ml in 1L.  The media was then collected and centrifuged to remove all cells and debris.  
After centrifugation, the media was concentrated and buffer exchanged against Ni-NTA 
Wash Buffer (50 mM NaH2PO4, 300 mM NaCl, pH 8.0) using Hydrosart filters (Sartorius, 
Edgewood, NY) in the Vivaflow 200 (Sartorius, Edgewood, NY).  After the concentration 
and buffer exchange, the media was loaded onto a 500 µL column of Ni2+-Nitriloacetic acid 
(Ni-NTA, Qiagen, Valencia, CA) agarose.  After all media passed through the column, the 
column was washed two times with 4 column volumes of Ni-NTA Wash Buffer and eluted 
five times with ½ the column volume of Ni-NTA Elution Buffer (50 mM NaH2PO4, 300 mM 
NaCl, 500 mM imidazole, pH 8.0).  All elutions were pooled and dialyzed 24 hrs at 4oC 
against 1X PBS with two buffer changes.  After dialysis, the elution sample was concentrated 
using Amicon Ultra-15 YM-10 centrifugal filter devices (10 kDa MWCO, Millipore, 
Billerica, MA).  Protein concentrations and purity were determined by Bradford analysis and 
SDS-PAGE, respectively.  The final concentration of protein was 50-100 µg/ml.  Purified 
protein was stored at -20oC until needed. 
SDS-PAGE and immunoblot analysis 
 For SDS-PAGE, all samples were electrophoresed under reducing conditions by 
either 10% SDS-PAGE or 4-12% SDS-PAGE.  Gels were then stained using SimplyBlue 
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SafeStain (Invitrogen, Carlsbad, CA) following the instructions of the manufacturer.  For 
immunoblots, following separation by SDS-PAGE under reducing conditions, samples were 
transferred to nitrocellulose membranes by semi-dry transfer at 380 mA for 60 min.  
Membranes were then blocked with 1X Tris-buffered saline (TBS), 2% milk for 12-16 hrs. at 
4oC.  Mouse anti-V5 monoclonal antibody (Invitrogen, Carlsbad, CA) was diluted 1:5000 in 
1X TBS, 2% milk and incubated with membranes for 1 hr at room temperature.  Membranes 
were next incubated with alkaline phosphatase (AP) conjugated goat anti-mouse antibody 
(Sigma, St. Louis, MO) diluted 1:1000 in 1X TBS, 2% milk for 45 min at room temperature.  
For C3a blots, rabbit anti-human C3a antibody (CompTech, Tyler, TX) was diluted 1:1000, 
and secondary AP-conjugated goat anti-rabbit IgG (Sigma) was diluted 1:1000 in 1X TBS, 
2% milk.  Bound antibody was detected directly on the membranes using the phosphatase 
substrate, 5-bromo-4-chloro-3-indolyl-phosphate/nitroblue tetrazolium (BCIP/NBT) (KPL).   
Deglycosylations with PNGase F and TFMS 
 To remove N-linked glycans from S20L12 and S20L2, approximately 0.5 µg of 
purified protein from insect cells was digested with 30 U/µL of PNGase F (New England 
Biolabs, Ipswich, MA) following the instructions provided by the manufacturer.  Briefly, 
protein was denatured in 1X Glycoprotein Denaturing Buffer (0.5% SDS, 1% β-
mercaptoethanol) (New England Biolabs, Ipswich, MA) for 10 min at 100oC.  The denatured 
protein was then incubated with PNGase F in 1X G7 Buffer (50 mM sodium phosphate, pH 
7.5, New England Biolabs, Ipswich, MA) and 1% NP-40 for 24 hr at 37oC.  The 
deglycosylated protein was then analyzed by SDS-PAGE and immunoblots. 
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 To remove N- and O-linked glycans from S20L12 and S20L2, 2 µg of protein were 
treated with the Glycoprofile IV Chemical Deglycosylation Kit containing TFMS according 
to the manufacturer’s instructions (Sigma, St. Louis, MO). 
Erythrocyte lysis assays 
 In order to test the alternative pathway, RbEs (CompTech, Tyler, TX) were washed 
three times with 5 volumes of AP Buffer (5 mM MgCl2, 5 mM EGTA in gelatin veronal 
buffer (GVB), CompTech, Tyler, TX), and resuspended to a final concentration of 2.0 x 108 
cells/ml in AP buffer.  Prior to performing the alternative pathway assays, the dilution of 
NHS (CompTech, Tyler, TX), normal mouse serum (NMS) (courtesy of C. Elkins, UNC-
Chapel Hill), or normal pig serum (NPS) (courtesy of T. Kawula, UNC-Chapel Hill) 
resulting in 80-90% lysis of the RbEs was determined and used for experimental assays.  
Experimental and control proteins were serially diluted in 1X PBS and added to NHS in AP 
buffer.  The volume of protein sample used for each reaction remained constant, keeping 
concentrations of divalent cations and chelators invariable.  The final volume of the mixture 
was 25 µL.  This mixture was then incubated with 25µL of washed, resuspended RbEs (2 x 
108 cells/ml) in disposable borosilicate glass culture tubes for 30 min at 37oC.  Control 
reactions contained RbEs (2 x 108 cells/ml) incubated with only NHS, NMS, or NPS in AP 
buffer or AP buffer alone. After incubation, 75 µL of N-saline was added to each tube.  The 
tubes were then centrifuged at 1000 g for 5 min to pellet all remaining intact RbEs.  
Supernatants were collected and loaded into 96-well plates.  The O.D. of the supernatants 
was measured at a λ of 405 nm.  In order to test the classical pathway, assays were performed 
as described for the alternative pathway using antibody-sensitized sheep erythrocytes (SEs) 
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(CompTech, Tyler, TX) and GVB++ (GVB with Ca2+ and Mg2+) (CompTech, Tyler, TX) 
instead of RbEs and AP Buffer.   
Human C3 or fB deposition ELISAs  
To determine if S20L12 or S20L2 inhibited the deposition of human C3 or fB onto 
surfaces, we performed deposition ELISAs using agarose coated plates following a modified 
protocol of Ribeiro and Valenzuela et al. (22, 34).  In the presence of polysaccharides, C3 is 
activated and covalently attaches to the sugars (36).  fB then noncovalently binds bound C3b.  
Since agarose is made of primarily galactose, C3 is activated in the presence of agarose and 
attaches covalently to agarose surfaces (22, 34).  Briefly, 96-well plates were coated with 100 
µL of 0.1% agarose in water.  The agarose in the plates was dried for 48 hrs at 37oC.  Once 
dry, 50 µL of AP buffer containing a 1:4 dilution of NHS and S20NS, S20L12, S20L2, or 
CAT at various concentrations were added to the wells and incubated at 37oC for 30 min.  In 
some reactions, S20NS, S20L12, S20L2, or CAT were added 30 min after the addition of 
NHS and the wells were incubated an additional 20 min at 37oC.  Control wells lacked NHS 
or contained 25 mM EDTA and NHS.  After incubation with NHS, the plates were washed 3 
times, 5 min each on an orbital shaker, with 200 µL/well of 1X TBS containing 10 mg/ml 
bovine BSA and 2 mM MgCl2.  After washing, 100 µL of a 1:1000 dilution of goat α-human 
C3 antibody (CompTech, Tyler, TX) or goat α-human fB antibody (CompTech, Tyler, TX) 
in 1X TBS, 10 mg/ml BSA, 2mM MgCl2+ was added to each well and the plate was 
incubated 1 hr at 37oC.  The plate was then washed 3 times as previously described, and 100 
µL of either a 1:5000 or 1:1000 dilution of an AP-conjugated rabbit α-goat IgG (Sigma, St. 
Louis, MO) was added to each well.  The plate was incubated 45 min at 37oC.  Following the 
incubation, the plate was washed 2 times, 5 min each, with 200 µL/well of 1X TBS, 10 
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mg/ml BSA.  The plate was next washed once with 1X TBS, 10 mg/ml BSA, 0.1% Tween 
followed by an additional wash with N-saline.  After washing, 100 µL of Sigma Fast PNPP 
(Sigma, St. Louis, MO) was added to each well and the plate was incubated at room 
temperature for 15 min.  After incubation, the O.D. was measured at a λ of 405 nm.    
Assays to detect S20L12 and S20L2 binding to properdin, TSP-1, or ADAMTS-13 
To detect direct binding of S20L12 and S20L2 to properdin, we performed 
immunoprecipitations and analyzed the precipitates by immunoblot.  S20L12 or S20L2 (150 
ng) were incubated with properdin (450 ng) at 37oC for 30 min in Binding buffer (PBS, 75 
mM NaCl, 10 mM MgCl2, 0.05% Tween) and then added to blocked Protein-A sephadex 
beads (Sigma) coated with 1 µg of mouse α-V5 IgG for 1 hour at 37oC.  The sephadex beads 
were washed and resuspended in non-reducing SDS-PAGE loading dye.  Samples were 
subjected to SDS-PAGE and immunoblotting with antibodies specific for either S20NS or 
properdin. 
As an alternative method to detect S20NS, S20L12, or S20L2 binding to properdin, 
microtiter plate wells were first coated with 100 ng/well of S20NS, S20L12, S20L2, CAT, or 
C3b for 12 h at 4oC.  The wells were then blocked and incubated with 100 ng/well properdin 
for 1 h at 37oC.  After incubation, the wells were washed.  To detect plate bound properdin, 
the wells were incubated with a primary goat α-properdin Ab and a secondary AP-
conjugated rabbit α-goat IgG. 
To detect S20NS, S20L12, or S20L2 binding to thrombospondin-1 (TSP-1), a 
disintegrin and metalloproteinase with a thrombospondin type I motif member 13 
(ADAMTS-13), or properdin, microtiter plates were first coated with 100 ng/well of TSP-1, 
ADAMTS-13, or properdin in 0.1 M Carbonate Buffer for 12 h at 4oC.  Wells were then 
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blocked with Binding buffer for 15 min at 23oC.  After blocking, 1 µg/ml of S20NS, S20L12, 
or S20L2 in Binding buffer were incubated in the wells for 1 hr at 37oC.  After the 
incubation, the wells were washed with TBST and bound protein was detected by standard 
ELISAs using a primary monoclonal mouse α-V5 IgG and a secondary AP-conjugated goat 
α-mouse IgG antibody.      
Saturation Binding Assays 
  To determine the relative binding affinity of properdin for S20NS, S20L12, S20L2, or 
C3b we performed a solid-phase binding assay.  Microtiter plates were coated with a 
saturating amount of S20NS, S20L12, S20L2, or C3b (10 ng/well) for 12 hrs at 4oC in 0.1M 
Carbonate Binding Buffer, pH 9.2.  After coating, the wells were blocked with Binding 
buffer (PBS, 75 mM NaCl, 10 mM MgCl2, 4% BSA, 0.05% Tween) for 1 hr at 37oC and then 
incubated with increasing concentrations of properdin in Binding buffer (PBS, 75 mM NaCl, 
10 mM MgCl2, 0.05% Tween) at 37oC for 1 hr  The wells were then washed with TBST, and 
bound properdin was detected by an ELISA using a primary goat α-human properdin Ab and 
a secondary AP-conjugated rabbit α-goat Ab.  Development of the substrate was stopped 
after 3 min by the addition of 3M NaOH.  The OD405 was determined and plotted, and 
relative Kd and Bmax values were calculated using GraphPad Prism 4 (GraphPad Software). 
 
4.4 Results 
Expression and characterization of S20L12 and S20L2 
 To examine the functional activities of additional ILP family members, we expressed 
two ILP members, S20Lclone 12 and S20Lclone 2, in an insect cell expression system.  
S20Lclone 12 shares 95% amino acid identity with Salp20 and possesses a putative secretion 
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signal, 7 N-linked glycosylation sites, several potential C-terminal O-linked glycosylation 
sites, and 4 conserved cysteines in the mature protein (Fig 4.1A).  S20Lclone 2 shares only 
65% amino acid identity with Salp20 but also possesses a putative secretion signal and 4 
conserved cysteines in the mature protein.  However, unlike Salp20 and S20Lclone 12, 
S20Lclone 2 only contains 5 potential N-linked glycosylation sites and displays multiple 
amino acid deletions at positions 116, 129-134, and 167-168, possibly resulting in fewer C-
terminal O-linked glycosylation sites (Fig 4.1A).         
     Recombinant S20L12 (S20Lclone 12 containing C-terminal V5 epitope and 6X-
histidine tag) and S20L2 (S20Lclone 2 containing C-terminal V5 epitope and 6X-histidine 
tag) were produced in insect cells similarly to S20NS as described in Chapter 2.  S20L12 and 
S20L2 were both efficiently expressed and secreted from stably transfected insect cells, as 
both proteins were found primarily in the culture media by Western blot (Fig 4.2B).  
Interestingly, similar to S20NS, S20L12 and S20L2 appeared to be ~ 50 kDa and 48 kDa, 
respectively, much larger than their predicted sizes of 24 kDa and 23 kDa, respectively.  In 
addition, S20L12 and S20L2 migrated as smears by Western blot, indicating the presence of 
differentially post-translationally modified forms of the proteins.  Since S20NS appeared as a 
smear by Western blot and displayed a size discrepancy between predicted and observed 
sizes primarily because of the addition of N- and O-linked glycosylations (32), we expected 
S20L12 and S20L2 likely contained carbohydrate modifications.   
 To determine if S20L12 and S20L2 contained N- and O-linked glycosylations, we 
digested the proteins with PNGase F, a glycosidase that removes N-linked carbohydrates, or 
treated them with TFMS, an acid that removes N- and O-linked carbohydrates without 
destroying the peptide backbone.  After incubations with PNGase F, S20L12 shifted from ~ 
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50 kDa to ~ 45 kDa, while S20L2 shifted from ~ 48 kDa to ~ 40 kDa, indicating the presence 
of N-linked glycans on both proteins (Fig 4.1C).  After TFMS treatment, S20L12 shifted 
from ~ 50 kDa to ~ 34 kDa, while S20L2 shifted from ~ 48 kDa to ~ 34 kDa, indicating the 
presence of N- and O-linked glycans on both proteins (Fig 4.1C).  Together, these results 
suggest that S20L12 and S20L2 both contain N- and O-linked glycosylations, similar to 
S20NS.   
Inhibition of the alternative complement pathway by S20L12 and S20L2 
To determine if S20L12 and S20L2 inhibited the alternative complement pathway, we 
performed RbE lysis assays as described in Chapter 2.  S20L12 and S20L2 (1 µg/ml) 
inhibited approximately 50% RbE lysis by NHS, similar to the activity of S20NS (Fig 4.2A).  
Comparable to S20NS, S20L12 and S20L2 were also incapable of completely blocking RbE 
lysis by NHS (Fig 4.2A) (32).  If S20NS, S20L12, and S20L2 are secreted in tick saliva 
simultaneously during feeding, then they may display synergistic effects, completing 
blocking host complement components.  To determine if ILP family members acted 
synergistically, S20L12, S20L2, and S20NS were mixed and incubated with NHS in the 
presence of RbEs.  When mixed together, the ILPs displayed an IC50 of 0.687 µg/ml, similar 
to the IC50 of individual ILPs.  These results suggest that ILP family members likely do not 
exhibit synergistic effects when secreted into a host during tick feeding. 
Experiments were done to test if S20L12 and S20L2 inhibited the classical 
complement pathway.  To test inhibition in the classical pathway, antibody sensitized 
erythrocytes (SEs) were incubated with NHS in the presence of S20L12 or S20L2 and Mg2+ 
and Ca2+.  After incubation, whole cells and cellular debris were pelleted by centrifugation.  
We then calculated the percent lysis of the SEs by measuring the optical density of the 
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supernatants.  S20L12 and S20L2 did not inhibit the classical pathway, consistent with the 
activity of tick saliva, Isac, and S20NS (15, 22, 34, 37) (Fig 4.2B).  
Dissociation of the C3 convertase by S20L12 and S20L2 
 Since S20NS inhibited the alternative complement pathway by preventing assembly 
and causing dissociation of the C3 convertase (32), we wanted to determine if S20L12 and 
S20L2 also inhibited the alternative pathway by a similar mechanism. To examine the effects 
of S20L12 and S20L2 on the C3 convertase, we formed C3 convertases using the agarose-
based ELISA described in Chapter 2.  In this assay, C3 is activated in the presence of agarose 
and Mg2+, covalently attaching to the agarose.  fB then binds to covalently bound C3b and is 
cleaved by fD, resulting in the formation of surface-bound C3 convertases (C3bBb).  Bound 
complement components are then detected by standard ELISAs with specific antibodies.  
S20L12 and S20L2 prevented the deposition of C3b and fB when added simultaneously with 
NHS to agarose coated microtiter wells (Fig 4.3A & B).  When S20L12 and S20L2 were 
added 30 min after NHS, they did not displace covalently bound C3b (Fig 4.3A & B).  
However, when added 30 min after NHS, S20L12 and S20L2 dissociated fB from C3b (Fig 
4.3A & B).  These activities are indistinguishable from the activities of both Isac and S20NS 
(32, 34), indicating that multiple ILP family members inhibit the alternative complement 
pathway by destabilizing the C3 convertase.  
S20L12 and S20L2 bind properdin       
 S20NS inhibits the alternative complement pathway by specifically binding 
properdin, a positive regulator of the C3 convertase (Chapter 3).  S20NS displaces properdin 
from the C3 convertase, promoting decay acceleration of the convertase.  Since S20L12 and 
S20L2 dissociate the C3 convertase similar to S20NS, we wanted to further establish if 
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S20L12 and S20L2 directly interacted with properdin.  In order to detect a direct interaction 
between S20L12 and S20L2 and properdin, we incubated S20L12 and S20L2 with properdin, 
immunoprecipitated S20L12 or S20L2 with an antibody directed against the C-terminal V5-
epitope tag, and analyzed the precipitates for the presence of properdin by Western blots.  
Both S20L12 and S20L2 directly interacted with properdin, similar to S20NS, as properdin 
was detected in precipitates only in the presence of S20L12 or S20L2 (Fig 4.4A).  To 
confirm this interaction, we also preformed binding ELISAs.  Microtiter plate wells were 
coated with S20NS, S20L12, S20L2, CAT (negative control), and C3b (positive control) and 
then incubated with properdin.  Bound properdin was detected by standard ELISAs with 
specific antibodies.  Properdin directly bound S20L12 and S20L2, similar to S20NS and C3b 
(Fig 4.4B).  These results confirm a direct interaction between properdin and multiple ILP 
family members, specifically S20NS, S20L12, and S20L2.   
Relative binding affinities of properdin for different ILP family members     
 Based on our studies, S20NS, S20L12, and S20L2 inhibited the alternative 
complement pathway by directly binding properdin and accelerating decay of the C3 
convertase.  As these ILP family members are likely expressed simultaneously during tick 
feeding, we wanted to determine any differences between them, justifying the necessity for 
their co-expression.  In order to identify differences between ILP family members, we first 
examined the possibility that different ILP family members exhibit different binding 
affinities for human properdin.  As S20L2 contains several C-terminal amino acid deletions, 
it may display a lower binding affinity for properdin (Fig 4.1A).  In order to determine 
relative binding affinities of ILP family members, we performed solid-phase saturation 
binding assays.  Microtiter wells were coated with properdin and then incubated with 
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dilutions of S20NS, S20L12, and S20L2.  After incubation, the wells were washed and bound 
ILP family members were detected with an antibody directed against the C-terminal V5-
epitope tag.  The binding affinities of properdin for S20NS, S20L12, or S20L2 were similar, 
as the relative calculated dissociation constants (Kd) were 1.129, 0.8566, and 1.027 nM, 
respectively (Fig 4.5).  Furthermore, the maximum numbers of binding sites (Bmax), as 
indicated by the OD405 value where saturation occurs, were also comparable between S20NS, 
S20L12, and S20L2 (Fig 4.5).  These results indicate that multiple ILP family members bind 
properdin with similar affinities.  Therefore, ILP family members may display other 
functional differences.   
Inhibition of the alternative complement pathway in various hosts by ILP family 
members      
I. scapularis feeds on a wide range of hosts including various small and large 
mammals, birds, and even reptiles (9, 29).  To feed successfully without host recognition and 
rejection, the tick must suppress hemostatic, inflammatory, and immune responses, including 
complement activation.  In order to block the alternative complement pathway in numerous 
hosts by binding properdin, which contains amino acid variations between different hosts 
(18), the tick may produce multiple ILP family members that could preferentially bind 
properdin from specific hosts.  To test this possibility, we performed erythrocyte lysis assays 
using serum collected from three animal hosts (mice, pigs, and humans) and evaluated the 
complement inhibitory activity of S20NS, S20L12, and S20L2.  In the presence of NHS and 
NPS, 1 µg/ml of S20NS, S20L12, and S20L2 displayed maximum inhibition of RbE lysis 
(Fig 4.6A & C).  In the presence of NMS, 1 µg/ml of S20NS and S20L12 and 5 µg/ml S20L2 
displayed maximum inhibition of RbE lysis (Fig 4.6B), suggesting S20NS and S20L12 may 
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preferentially inhibit complement components in NMS over S20L2.  However, when tested 
repeatedly, these variations in inhibition of RbE lysis were not consistent.   These results 
demonstrate that different ILP family members display no significant differences in their 
inhibitory activities against the alternative complement pathways from various hosts. 
Binding of ILP family members to TSR containing proteins  
 The majority of properdin, ~ 80%, is composed of 6 TSRs, which are flanked by short 
N- and C-terminal sequences (18).  TSRs are approximately 60 amino acids and are found in 
a variety of proteins where they facilitate protein-protein interactions (1, 31).  In properdin, 
the TSRs are necessary for binding C3b or the C3 convertase (11, 21).  TSP-1, a protein 
involved in platelet aggregation, inflammation, and angiogenesis during wound healing, and 
ADAMTS-13, a metalloproteinase that cleaves von Willebrand’s factor, both contain 
multiple TSRs (5, 14, 25).  As several ILP family members are likely expressed during tick 
feeding, they may serve additional roles besides complement inhibition.  By binding the 
TSRs of properdin and other TSR-containing proteins, such as TSP-1 and ADAMTS-13, ILP 
family members may display multiple functions, potentially inhibiting the alternative 
complement pathway, platelet aggregation, and inflammation.  In order to test this 
possibility, we performed binding ELISAs with ILP family members and various TSR-
containing proteins.  Microtiter wells were coated TSP-1, ADAMTS-13, or properdin and 
then incubated with S20NS, S20L12, S20L2, and CAT (negative control).  Bound ILP family 
members were detected by ELISA with specific antibodies.  S20NS, S20L12, and S20L2 
specifically interacted with only properdin (Fig 4.7), indicating ILP family members likely 
only interact with properdin and not other TSR-containing proteins.  
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4.5 Discussion    
 In this study, we addressed the functions of additional ILP family members, 
S20Lclone 12 and S20Lclone 2.  We successfully expressed and purified recombinant 
S20L12 and S20L2 from insect cells.  Like S20NS, S20L12 and S20L2 possessed both N- 
and O-linked glycosylations, resulting in much larger sizes than predicted.  Additionally, 
S20L12 and S20L2 inhibited the alternative complement pathway by directly interacting with 
properdin.  Properdin bound S20NS, S20L12, and S20L2 with similar affinities, suggesting 
that multiple ILP family members share similar complement inhibitory activities.  
 A family of salivary anti-complement proteins has also been identified in I. ricinus 
ticks, which are closely related to I. scapularis.  Daix et al. identified and expressed Irac-1 
and Irac-2, which both inhibit the alternative complement pathway by destabilizing the C3 
convertase.  In addition, Daix et al. determined that Irac-1 and Irac-2 are co-expressed in a 
single tick during feeding by IFA of individual salivary gland pairs from adult engorged 
females with monoclonal antibodies directed against either Irac-1 or Irac-2 (7).  Couvreur et 
al. identified additional I. ricinus anti-complement proteins related to Irac-1 and Irac-2 and 
determined that they were also co-expressed in unfed and fed larval, nymphal, and adult ticks 
(6).  Based on these observations, it is likely that Salp20, Isac, S20L12, and S20L2 are co-
expressed in I. scapularis ticks during feeding.  We next wanted to determine the reason for 
ticks to co-express multiple ILP family members with identical functions during feeding.   
 Several possibilities exist to explain why the tick would need to co-express a large 
family of anti-complement proteins with the same functions.  One possibility is that ILP 
family members potentially display synergistic inhibitory effects when co-expressed during 
feeding, completely blocking host complement activation.  In this study, we examined this 
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possibility by performing erythrocyte lysis assays in the presence of a mixture of S20NS, 
S20L12, and S20L2.  This mixture of ILP proteins displayed no synergistic inhibitory effects 
when compared to the inhibitory effects of individual ILP family members.   
 Another reason to co-express multiple ILP family members is that different family 
members may display host specificity, preferentially binding properdin from specific animal 
hosts.  This is a plausible possibility as ixodid ticks, especially I. scapularis, feed on a wide 
variety of hosts including mammals, birds, and reptiles (9, 29).  In this study, we tested this 
possibility by performing lysis assays in the presence of S20NS, S20L12, and S20L2 with 
NHS, NMS, or NPS.  We detected no significant differences in the inhibitory activities of the 
ILP family members between the different animal serum samples.  Since we only tested three 
different serum sources, it is possible that different ILPs display host specificity between 
other animal sources.  However, Couvreur et al. and Schroeder et al. have demonstrated that 
I. ricinus anti-complement proteins display similar inhibitory activities against sera from 
several animals, birds, and reptiles, suggesting I. ricinus and potentially I. scapularis ILPs do 
not display host specificity (6, 26). 
 A third possibility justifying the co-expression of multiple ILP family members 
during tick feeding is that the ILP family members are potentially multifunctional.  Since the 
ILP family members directly interact with properdin, and properdin is primarily composed of 
TSRs, then the ILP family members may potentially interact with other TSR-containing 
proteins and inhibit additional host hemostatic, inflammatory and immune responses.  In 
order to test this possibility, we incubated S20NS, S20L12, and S20L2 with various TSR-
containing proteins including TSP-1, ADAMTS-13, and properdin.  The ILP family members 
specifically interacted with only properdin, indicating ILP family members most likely do 
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not bind other TSR-containing proteins.  However, numerous proteins involved in various 
cellular responses including platelet aggregation, angiogenesis, cell matrix remodeling, and 
neuronal development contain TSRs.  Since we only examined the interactions of S20NS, 
S20L12, and S20L2 with TSP-1 and ADAMTS-13, the possibility still exists that ILP family 
members may directly interact with other TSR-containing proteins.  Furthermore, the ILP 
family members may serve additional functions important for tick physiology.  Daix et al. 
and Couvreur et al. determined that I. ricinus anti-complement proteins are constituitively co-
expressed in unfed ticks, possibly suggesting they may serve important roles in the tick when 
it is not feeding (6, 7).  
 In this study, we determined that ILP family members do not display synergy or host 
specificity, and they do not bind additional TSR-containing proteins. Other possibilities still 
exist to explain the co-expression of multiple ILPs in the tick, including: 1) differential 
expression of ILP family members during different life stages of the tick 2) differential target 
recognition between ILP family members and 3) antigenic variation between different ILP 
family members.  It is not likely that specific ILPs are expressed during specific life stages 
since the ILP family members examined in this study, Salp20, S20Lclone 12, and S20Lclone 
2, are co-expressed during the nymphal life stage of the tick (8, 32).  Furthermore, Couvreur 
at al. have demonstrated that multiple I. ricinus anti-complement proteins are co-expressed 
during all life stages of the tick (6). 
 Various ILP family members may be co-expressed during tick feeding because 
different family members potentially bind different domains within the target protein, 
properdin.  Properdin is primarily composed of 6 TSRs, which are flanked by short N- and C-
terminal regions (18).  In plasma, properdin typically exists as dimers, trimers, or tetramers, 
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with tetramers and trimers being the most active forms of the protein (20).  TSR-6 of 
properdin facilitates polymerization, while TSR-5 mediates C3b interactions (11, 21).  
Different ILP family members may bind different domains of properdin, blocking its 
polymerization or its interaction with C3b, which would ultimately result in C3 convertase 
decay acceleration.  Spitzer et al. have also demonstrated that properdin binds surfaces 
independently of C3b, acting as a platform to initiate convertase formation and complement 
activation (30).  The domains mediating the interaction of properdin with activating surfaces 
are currently unknown, but various ILP family members may also bind these domains, 
blocking the interaction of properdin with activating surfaces and preventing activation of the 
alternative complement pathway.  We are currently examining the domains of properdin that 
are necessary for binding S20NS, S20L12, and S20L2.   
 There is a high probability that various ILP family members display antigenic 
variation.  Since I. scapularis ticks feed for several days on a host and repeatedly feed on the 
same host, the host has ample time to mount immune responses, including the generation of 
neutralizing antibodies, against various tick salivary proteins.  Therefore, the tick may need 
to produce multiple proteins with identical functions that are antigenically variable in order 
evade host immune responses and prevent complement activation.  In support of this theory, 
Couvreur et al. have recently established that antibodies generated against a specific I. 
ricinus anti-complement protein, IxAC-B1, only detect and neutralize the activity of IxAC-
B1 and none of the other I. ricinus anticomplement proteins (6).  Additionally, Kotsyfakis et 
al. have demonstrated that two I. scapularis salivary sialostatins, which bind and inhibit host 
cathepsins, also display antigenic variation (13).  Based on these findings, Isac, Salp20, 
S20Lclone 12, and S20Lclone 2 also likely display antigenic variation.  At this time, we are 
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investigating this possibility.  Characterization of the functions, properties, and differences of 
various ILP family members will provide further insight into the mechanisms of salivary 
proteins important for tick feeding and aid in the development of anti-tick vaccines. 
 
4.6 Contributions   
 In this work, I designed and performed the experiments.  Holly Patterson, a lab 
technician under my direction, produced and purified of recombinant insect proteins used in 
this study, including S20NS, S20L12, and S20L2.  Aravinda de Silva assisted with the design 
of experiments.   
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 Figure 4.1 Alignment, expression, and deglycosylation of S20L12 and S20L2. A. Amino 
acid alignment of Isac, Salp20, S20Lclone 2, and S20Lclone 12.  Putative secretion signals 
are boxed, potential N-linked glycosylation sites are marked with arrows, and conserved 
cysteines are marked with asterisks.  Yellow highlighted amino acids indicate conservation 
among all 4 sequences while blue highlighted amino acids indicated conservation among 2 or 
3 sequences. B. Western blot using a mouse monoclonal α-V5 antibody of culture media 
from stably transfected insect cells expressing CAT (~34 kDa), S20L12 (~ 50 kDa), S20L2 
(~ 48 kDa), or S20NS (~ 50 kDa). C. SDS-PAGE of RNaseB (positive control for 
deglycosylation with TFMS), S20NS, S20L12, and S20L2 treated with either PNGaseF or 
TFMS.  Arrows indicate native and deglycosylated proteins.      
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 Figure 4.2 Inhibition of the alternative complement pathway by S20L12 and S20L2. RbEs 
(A) or SEs (B) were incubated with increasing concentrations S20NS, S20L12, S20L2, CAT, 
or a mixture of ILP family members in the presence of NHS.  After lysis occurred, cells and 
cell debris were pelleted, and the O.D.405 of the supernatants was determined and the percent 
lysis was calculated.  The error bars represent the standard error of the mean % lysis where 
N=3. 
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Fig 4.3 Deposition of C3 or fB in the presence of S20L12 and S20L2.  S20NS, S20L12, 
S20L2, or CAT (1 µg/ml) were added to the agarose wells of a 96-well plate either 
immediately with NHS (0 min) or 30 min after NHS (30 min).  The wells were washed and 
plate bound C3 (A) or fB (B) were detected with specific antibodies.  The error bars 
represent the standard error of the mean O.D. value where N=3. 
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Fig 4.4 S20L12 and S20L2 directly bind properdin.  A. S20L12 (L12), S20L2 (L2), 
properdin (P), or S20L12 and S20L2 previously incubated with properdin (L12+P and L2+P, 
respectively) were immunoprecipitated (IP) with a monoclonal α-V5 Ab against the C-
terminal epitope tags on S20L12 and S20L2.  Immunoprecipitates were then analyzed by 
Western Blots using specific Abs directed against properdin (α-fP) or S20L12 and S20L2 (α-
His).  B. Microtiter plate wells were coated with S20NS, S20L12, S20L2, CAT (negative 
control), or C3b (positive control).  The wells were washed, blocked, and then incubated with 
properdin.  Bound properdin was detected by ELISA.  The error bars represent the standard 
error of the mean where N=3.   
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 Fig 4.5 Saturation binding curves and relative binding affinities of properdin for ILP family 
members.  Microtiter plate wells were coated with S20NS, S20L12, or S20L2.  Increasing 
concentrations of properdin were then added to the wells, and bound properdin was detected 
by ELISA.  The error bars represent the standard error of the mean where N=9.    
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Fig 4.6 Inhibition of complement from various mammalian hosts by ILP family members.  
RbEs were incubated with NHS (A), NMS (B), or NPS (C) in presence of Mg2+ and 
increasing concentrations of S20NS, S20L12, S20L2, or CAT.  After lysis, whole cells and 
cell debris were pelleted by centrifugation.  The O.D.405 of the supernatants was determined 
and the % lysis calculated.  The error bars represent the standard error of the mean where 
N=3.   
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 Fig 4.7 Binding of ILP family members to different TSR-containing proteins.  Microtiter 
wells were coated with TSP-1, ADAMTS-13, or properdin.  The wells were then blocked and 
incubated with S20NS (1 µg/ml), S20L12 (1 µg/ml), S20L2 (1 µg/ml), or CAT (1 µg/ml).  
Bound S20NS, S20L12, S20L2, or CAT was detected with a mouse monoclonal α-V5 
antibody.  The error bars represent the standard error of the mean where N=3. 
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5.1 Abstract 
 I. scapularis ticks secrete numerous salivary proteins that inhibit host hemostasis, 
inflammation, and immunity.  A large family of I. scapularis salivary anti-complement 
proteins, the ILP family, inhibits the alternative complement pathway, preventing the 
generation of multiple anaphylatoxins and the lysis of tick cells by complement.  Several 
members of the ILP family specifically inhibit complement activation by directly binding the 
positive regulator of the alternative complement pathway, properdin.  This interaction 
prevents the assembly of C3 convertases and causes the dissociation of pre-assembled 
convertases.  Currently, it is unknown if the activities of ILP family members are required for 
tick feeding.  In this work, we have evaluated the importance of salp20 and related ILP 
family member gene expression during tick feeding through gene silencing by RNAi.  
Microinjection of siRNAs into nymphal ticks, regardless of the target gene specificity, 
 
resulted in reduced tick attachment.  As an alternative approach to evaluate the importance of 
the ILP family during tick feeding, we also immunized mice with recombinant insect 
expressed ILPs and then fed ticks on the immunized mice.  Nymphal I. scapularis ticks fed 
successfully and efficiently on mice with antibodies directed against multiple salivary ILPs. 
 
5.2 Introduction 
 Members of the ILP family, which includes Isac, Salp20, S20Lclone 12, S20Lclone 
2, Irac-1, Irac-2, and IxACs, inhibit the alternative complement pathway, preventing various 
host responses that could be detrimental to the tick (2, 3, 10, 11).   Salp20, S20Lclone12, 
S20Lclone 2, Irac-1, Irac-2, and multiple IxACs specifically bind properdin, preventing C3 
convertase formation and causing decay acceleration of preformed convertases (2, 3, 10) 
(Chapter 3).  Recent work suggests that multiple ILP family members are co-expressed and 
secreted into a host during tick feeding (2, 3).  These family members likely display antigenic 
variation, allowing them to evade host immune recognition, which ultimately permits the tick 
to effectively inhibit the alternative complement pathway and feed successfully (2).  
However, it is currently unclear if the ILP family is required for tick feeding. 
 RNAi is an effective tool that has been used successfully to knockdown the 
expression of various tick salivary proteins, including histamine-binding proteins, Salp14, 
Salp15, and Isac (1, 4, 6-8).  Using RNAi, we examined the role of Salp20 and additional ILP 
family members during tick feeding.  We first silenced salp20 and ILP family member genes 
in nymphal ticks by microinjection of siRNAs corresponding to conserved regions among the 
ILP family members.  We then evaluated any differences between mock-treated and siRNA-
injected ticks during attachment and feeding.  In addition to RNAi, we also immunized mice 
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with S20NS, S20L12, and S20L2 individually or in combination to generate antibody 
responses against the ILPs.  After immunization, we fed ticks on the immunized and mock-
treated mice and observed any differences in tick attachment and feeding.  
 
5.3 Materials and Methods       
Mice and Ticks 
 BALB/c mice, 4-6 weeks old, were purchased from Charles River Laboratories 
(Wilmington, MA).  Nymphal I. scapularis ticks used for RNAi experiments were provided 
courtesy of E. Fikrig (Yale Univeristy, New Haven, CT).  Mock-treated and siRNA-injected 
nymphal ticks were placed on BALB/c mice and allowed to feed for 60 hrs.  Ticks were then 
removed and dissected to obtain salivary glands and guts.  Nymphal I. scapularis ticks that 
were fed on immunized mice were raised as previously described by Sonenshine (9).  
Nymphal ticks were placed on immunized BALB/c mice and allowed to feed to repletion.  
Replete ticks that had fallen off the mice were then collected and weighed.    
RNA interference    
 RNAi experiments in I. scapaularis nymphs were performed following a modified 
protocol of Narasimhan et al. (4).  Duplex siRNAs corresponding to conserved regions 
among ILP family members and duplex nonsense siRNAs (Table 5.1) were synthesized 
(Invitrogen, Carlsbad, CA).  dsRNA corresponding to full-length salp20 was provided 
courtesy of E. Fikrig (Yale University, New Haven, CT).  Groups of 25 nymphal ticks were 
injected with approximately 4.6 nl of a mixture of siRNAs (~1 x 1015 molecules/µl) or 2.3 nl 
of dsRNA (~1 x 1010 molecules/µl) in the ventral torso of the idiosoma using a 
micromanipulator (Narishige, Tokyo) connected to a Nanojet II microinjector (Drummond 
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Scientific, Broomall, PA).  The needles attached to the micromanipulator were 3.5 inch 
capillaries (Drummond Scientific, Broomall, PA) drawn to a fine point with a micropipette 
puller (Sutter Instruments, Novato, CA).  Mock- treated ticks were injected with 2.3 nl of 
buffer (10 mM Tris-HCl, pH 8.0, 20mM NaCl, 1 mM EDTA).  After the injections, nymphal 
ticks were allowed to rest 3-4 hrs at 23oC in a humidity chamber.  The ticks were then placed 
BALB/c mice and allowed to feed for 60 hrs.  After feeding, the ticks were removed and 
dissected to obtain salivary glands and guts.   
RT-PCR to confirm gene silencing 
 In order to validate successful silencing of salp20 with siRNAs and dsRNA, we 
preformed RT-PCR on RNA extracted from the dissected salivary glands and guts of 
dsRNA-treated ticks.  Five pairs of salivary glands or 3 guts from siRNA, dsRNA, or mock 
treated fed ticks were dissected and placed in 150 µl of Trizol (Invitrogen, Carlsbad, CA).  
Glands were subsequently homogenized and RNA was extracted following the 
manufacturer’s directions.  Contaminating DNA was eliminated from purified RNA samples 
using the TURBO DNA-free kit (Ambion, Austin, TX) according to the protocol of the 
manufacturer.  cDNA was then generated from DNA-free RNA using the iScript cDNA 
synthesis kit (Bio-Rad, Hercules, CA) and the following primer sets: salp20F and salp20R, 
which were provided by E. Fikrig (Yale University, New Haven, CT), and β-actin F – 5`-
GATGACCCAGATCATGTTCG-3` and β-actin R – 5`-GCCGATGGTGATCACCTG-3`.  
PCR products were the analyzed by agarose gel electrophoresis for the presence of salp20 
and actin.   
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Immunizations with S20NS, S20L12, and S20L2 
 BALB/c mice were immunized subcutaneously with 10 µg of S20NS, S20L12, and 
S20L2 either individually or in combination in a 100 µl emulsion of PBS and Freund’s 
complete adjuvant (Sigma, St. Louis, MO).  Mice were then boosted subcutaneously 2 and 4 
weeks after the initial immunization with 10 µg of S20NS, S20L12, and S20L2 individually 
or in combination in 100 µl of PBS and Freund’s incomplete.  Mice were bled 1 week after 
the initial immunization and each boost by tail bleeds.  Serum was purified from the collected 
blood using microtainer serum separators (Becton Dickinson, Franklin Lakes, NJ) following 
the manufacturer’s instructions.  Nymphal ticks were placed on the mice 2 weeks after the 
final boost and allowed to feed to repletion.  Replete ticks were then collected and weighed.        
Western blot analysis for antibody detection and specificity 
 For Western blot analysis, ~100 ng of recombinant purified S20NS, S20L12, S20L2, 
and CAT, and 25 µl of culture media from insect cells expressing recombinant Salp20 
without the C-terminal V5-epitope and 6X-His tags (S20S) were electrophoresed under 
reducing conditions by 10% SDS-PAGE.  Samples were then transferred to nitrocellulose 
membranes by semi-dry transfer at 380 mA for 60 min.  Membranes were blocked with 1X 
Tris-buffered saline, 0.2% Tween-20 (TBST), 5% milk for 12-16 hrs at 4oC.  Mouse anti-V5 
monoclonal antibody (Invitrogen, Carlsbad, CA) or mouse sera from immunized mice were 
diluted 1:5000 and 1:100, respectively, in TBST and incubated with the membranes for 1 hr 
at room temperature.  Membranes were next incubated with horseradish peroxidase (HRP)-
conjugated goat anti-mouse antibody (Sigma, St. Louis, MO) diluted 1:10000 in TBST for 45 
min at room temperature.  Bound antibody was detected by chemiluminescence using the 
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ECL Plus detection kit (Amersham Biosciences (GE Healthcare), Buckinghamshire, UK) 
following the manufacturer’s instructions.   
ELISAs for antibody detection and specificity 
 For ELISAs, microtiter plates were coated with 100 ng/well S20NS, S20L12, S20L2, 
or CAT in 0.1 M Carbonate Buffer for 12 hrs at 4oC.  After coating, the wells were blocked 
for 1 hr at 37oC with 1X TBS, 0.1% BSA.  Sera from immunized mice were diluted 1:50 in 
1X TBS, 0.1% BSA and incubated in the blocked wells 1 hr at 37oC.  The wells were washed 
with TBST and subsequently incubated with an AP-conjugated goat anti-mouse antibody 
diluted 1:1000 in 1X TBS, 0.1% BSA.  Wells were washed and bound antibodies were 
detected by measuring the O.D.405 after the addition of PNPP (Sigma, St. Louis, MO).  
 
5.4 Results 
RNA interference in nymphal I. scapularis ticks 
 In order to assess the importance and necessity of Salp20 and other ILP family 
members during tick feeding, we silenced salp20 expression, and potentially other ILP 
family member gene expression, with siRNAs and fed siRNA-treated ticks on naïve mice.  
Three siRNAs were generated corresponding to conserved regions among the ILP family 
members (Table 5.1).  Since these siRNAs were conserved among different family members, 
they would likely silence multiple ILP genes.  Groups of 30 nymphal ticks were 
microinjected with either buffer (mock) or a mixture of the three siRNAs (salp20 siRNAs), 
allowed to rest, and then placed on naïve mice to feed.  All of the mock-injected ticks 
attached to the mice and fed normally.  Surprisingly, only 11 of the 30 salp20 siRNA-
injected ticks successfully attached to mice.  After feeding for 5 days, salivary glands and 
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guts were dissected from the fed nymphal ticks.  RNA was extracted from the salivary glands 
and guts and subjected to RT-PCR to determine the expression levels of salp20 and actin.  
Two groups of pooled salivary gland pairs and pooled guts from mock-injected ticks 
expressed both salp20 and actin, while two groups of pooled salivary gland pairs from 
salp20 siRNA-injected ticks expressed only actin and not salp20 (Fig 5.1).  Interestingly, 
salp20 and actin expression were detected in the guts of salp20 siRNA-injected ticks.  These 
results suggest that silencing of salp20 expression, and potentially other ILP family 
members, by RNAi reduces the ability of I. scapularis nymphs to successfully attach to a 
host.   
 In order to establish the lack of attachment we observed in the previous experiment 
was the result of salp20 siRNA specificity, we repeated the experiment and injected 4 groups 
of 15 ticks with buffer (mock), full-length salp20 dsRNA (salp20 dsRNA), salp20 siRNAs, 
or nonsense siRNAs (Table 5.1).  When the injected nymphal ticks were placed on mice, 
mock-injected and salp20 dsRNA-injected ticks attached successfully (Table 5.2).  However, 
the salp20 siRNA-injected and the nonsense siRNA-injected ticks failed to attach (Table 
5.2), indicating the presence of siRNA, regardless of target specificity, results in reduced I. 
scapularis attachment rates.   
Mouse immunizations with recombinant S20NS, S20L12, and S20L2 
 As an alternative approach for evaluating the importance and necessity of the ILP 
family during tick feeding and to examine the antigenic properties of ILP members, we 
immunized mice with recombinant S20NS, S20L12, and S20L2 either individually or in 
combination and subsequently fed nymphal ticks on the immunized mice.  Mice immunized 
with S20NS, S20L12, and S20L2 individually or in combination developed robust antibody 
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responses against the immunizing recombinant proteins and additional ILP family members.  
Antibodies in sera from mice immunized with a combination of S20NS, S20L12, and S20L2 
reacted against all three recombinant proteins when compared to pre-immune sera, while 
antibodies in sera from mice immunized with S20NS, S20L12, or S20L2 individually reacted 
against the recombinant protein used for the immunizations and additional ILP family 
members when compared to pre-immune sera (Fig 5.2A and data not shown).  Since all of 
the mice were immunized with recombinant proteins containing C-terminal V5-epitope and 
6X-His tags, antibodies may have developed against the tags resulting in cross-reactivity.  In 
support of this possibility all immunized mouse sera reacted weakly with CAT, which 
contains the C-terminal epitope tags (Fig 5.2A).  However, antibodies specific for the 
recombinant proteins without the tags were apparent as serum from a mouse immunized with 
S20NS detected a doublet by Western blot analysis in a sample containing culture media 
from insect cells expressing Salp20 without the C-terminal tags (S20S) (Fig 5.2B).  
Additionally, the proportion of antibodies specific for the V5-epitope and 6X-His tags was 
likely minimal since serum from the mouse immunized with S20NS barely detected CAT 
(Fig 5.2B). 
 After we determined immunized mice developed antibody responses against the 
recombinant ILPs, we placed nymphal I. scapularis ticks on the immunized mice.  All ticks 
attached and fed successfully to repletion on all immunized mice.  Fully engorged ticks that 
fed on immunized mice displayed no significant average weight differences from engorged 
ticks that fed on PBS-injected (mock) mice (Fig 5.3).  These results suggest that the antibody 
responses generated against the recombinant ILPs do not prevent successful I. scapularis 
attachment and feeding.  
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5.5 Discussion      
 In this study, we assessed the importance and necessity of Salp20 and related ILP 
family members during tick feeding by first performing RNAi assays.  For these assays, we 
microinjected nymphal ticks with siRNAs corresponding to conserved regions among the 
ILP family members and silenced salp20 expression, and possibly other ILP gene expression. 
Surprisingly, we were unable to detect differences in the number of ticks successfully 
attaching to mice when salp20 siRNA-injected ticks were compared to ticks that were 
microinjected with nonsense siRNAs.  These results indicate that the presence of siRNAs 
alone within ticks affects the ability of the tick to successfully attach to a host.  One 
explanation for this observed result is that high concentrations of siRNAs were injected into 
the ticks, perhaps resulting in abnormal tick behaviors.  In order to detect specific effects of 
silencing salp20 and related ILP gene expression, these experiments should be repeated with 
multiple dilutions of siRNAs to determine the tick attachment and feeding abilities at the 
appropriate concentration of siRNA that causes efficient specific gene silencing without 
displaying nonspecific side effects.   
 Our approach to silence salp20 and other related ILP family member genes with 
siRNAs was unique in that all successful RNAi studies in ticks thus far have typically been 
performed with full-length dsRNAs corresponding to the target gene, as opposed to siRNAs 
(1, 4, 6-8).  The stability and longevity of siRNAs within ticks is unknown.    Silencing of 
salp20 expression by microinjection of full-length salp20 dsRNA in nymphal I. scapularis 
ticks also had no effect on tick attachment, feeding times, or fed weights (personal 
communication, N. Ramamoorthi). Since salp20 dsRNA potentially silenced only salp20 
expression, other ILP genes may have been expressed resulting in no observed effects during 
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tick attachment and feeding.  Even though we successfully silenced salp20 expression with 
both siRNAs and dsRNA, we may observe more consistent and definitive results in tick 
attachment and feeding if we perform these studies using multiple full-length dsRNAs 
corresponding to several ILP family members.    
 Soares et al. demonstrated that capillary feeding of isac dsRNA effectively silenced 
isac expression and led to reduced nymphal tick weights during feeding, resulting in 
ineffective pathogen transmission (8).  However, in their approach, Soares et al. prefed 
nymphal ticks 72 hr before feeding them isac dsRNA.  During that 72 hrs, the ticks 
successfully attached and cemented themselves in place, making their removal extremely 
difficult.  In fact, during removal from the host, tick mouthparts are often damaged, which 
ultimately prevents further successful feeding and may even lead to premature death.  In their 
studies, Soares et al. may have damaged tick mouthparts during removal from the host, 
resulting in reduced tick weights when the ticks were allowed to feed again after isac dsRNA 
administration.  Furthermore, as Soares et al. administered only isac dsRNA to nymphal 
ticks, they may not have effectively silenced the entire ILP family.  More pronounced 
differences in feeding times and weights may be apparent between mock-treated and dsRNA-
treated ticks if the entire ILP family is effectively silenced. 
 Besides RNAi, we also developed specific antibodies against ILP family members to 
determine the importance of the ILP family during tick feeding and to additionally assess the 
antigenicity of various family members.  When mice were immunized with S20NS, S20L12, 
and S20L2 individually or in combination, they developed robust antibody responses against 
the ILPs.  However, these antibody responses did not prevent successful tick feeding as 
comparable numbers of fed nymphal ticks from all immunized mice and PBS-injected 
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(mock) mice displayed similar average weights.  One explanation for this result is that if the 
ILP family members indeed display antigenic variation, the antibodies generated in the 
immunized mice may have neutralized specific ILPs but not all family members secreted in 
tick saliva during feeding, allowing the ticks to feed successfully.  Couvreur et al. have 
demonstrated that antibodies in the serum from a mouse immunized with a single 
recombinant I. ricinus ILP detected and neutralized the activity of only the immunizing 
protein and not related family members, suggesting antigenic variation between family 
members (3).  In addition, Daix et al. determined that monoclonal antibodies directed against 
Irac-1 were only capable of recognizing Irac-1, and not Irac-2.  Likewise, Irac-2 monoclonal 
antibodies only recognized Irac-2, and not Irac-1 (3).  In the studies described here, 
antibodies from mice immunized with individual ILPs, S20NS, S20L12, and S20L2, were 
able to recognize all recombinant ILP proteins, suggesting antigenic variation may not be a 
likely possibility.  However, all of the recombinant ILP proteins possessed V5-epitope and 
6X-His tags, possibly resulting in the generation of cross-reactive anti-V5 and anti-His 
antibodies.  We did observe some cross-reactive anti-V5 and anti-His antibodies as sera from 
all immunized mice were capable of reacting with CAT, which is not an ILP but contains C-
terminal V5-epitope and 6X-His tags.  In order to draw conclusions about the antigenicity of 
various ILP family members and the necessity and importance of the ILP family during tick 
feeding, we must generate either monoclonal antibodies against specific family members or 
polyclonal sera lacking antibodies against the C-terminal tags present on all recombinant 
ILPs.   
 Besides difficulties with the antibody responses, we also may not have observed any 
differences in average fed tick weights between ticks that fed on mock-treated and 
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immunized mice because the ticks used for this study were nymphal ticks.  Narasimhan et al. 
demonstrated that silencing salp14 expression in adult I. scapularis ticks resulted in 
pronounced differences in fed tick weights between dsRNA-injected ticks and mock-treated 
ticks (4).  However, when Pedra et al. repeated these studies in nymphal ticks, no differences 
in fed tick weights were observed between salp14 dsRNA-injected and mock-treated ticks, 
indicating the feeding characteristics and tick rejection mechanisms are different between 
adults and nymphs (5).  Nymphal ticks are very small, making weight determinations 
difficult.  In addition, female and male nymphs appear identical, but females usually 
consume much larger blood meals than males (9).  In our studies, it is highly likely that male 
and female nymphs were distributed unevenly between feeding groups.  Therefore, 
significant differences in fed tick weights between dsRNA-injected and mock-treated and 
between ticks feeding on immunized versus mock-treated mice may be hard to distinguish.  
Both the RNAi and immunization experiments may provide clearer results if performed with 
adult I. scapularis ticks.  Once these experiments are eventually optimized, and if we are able 
to determine the ILP family is vital for successful tick feeding, various family members may 
be attractive targets for anti-tick vaccines.   
 
5.6 Contributions  
 In this work, I designed and performed all of the experiments with the following 
exceptions.  Nandhini Ramamoorthi, a postdoctoral fellow in the laboratory of Erol Fikrig, 
aided me in the design of the RNAi studies and assisted me with the microinjections of ticks 
with dsRNA and RT-PCR of dissected tick tissues.  Nandhini Ramamoorthi also provided 
full-length salp20 dsRNA as a control in the RNAi experiments.  Erol Fikrig provided 
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nymphal ticks and laboratory space for me to perform the RNAi studies, and Aravinda de 
Silva helped with the design of the experiments. 
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 siRNA Name Sequence 
Salp20_siRNA_157 5`-GCACAGUAUAGGAAUUCAA-3` 
Salp20_siRNA_157R 5`-UUGAAUUCCUAUACUGUGC-3` 
Salp20_siRNA_117 5`-CUACGAACGUCAAUAUAGA-3` 
Salp20_siRNA_117R 5`-UCUAUAUUGACGUUCGUAG-3` 
Salp20_siRNA_156 5`-GGCACAGUAUAGGAAUUCA-3` 
Salp20_siRNA_156R 5`-UGAAUUCCUAUACUGUGCC-3` 
nonsense_siRNA_157_rev 5`-AACUUAAGGAUAUGACACG-3` 
nonsense_siRNA_157R_rev 5`-CGUGUCAUAUCCUUAAGUU-3` 
nonsense_siRNA_117_rev 5`-AGAUAUAACUGCAAGCAUC-3` 
nonsense_siRNA_117R_rev 5`-GAUGCUUGCAGUUAUAUCU-3` 
nonsense_siRNA_156_rev 5`-ACUUAAGGAUAUGACACGG-3` 
nonsense_siRNA_156R_rev 5`-CCGUGUCAUAUCCUUAAGU-3` 
 
Table 5.1 siRNAs used for RNA interference in nymphal I. scapularis ticks. 
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 Fig 5.1 RT-PCR of RNA from the salivary glands and guts of mock- and salp20-siRNA 
injected I. scapularis nymphs.  RNA was extracted from two groups (1 & 2) of 5 pairs of 
salivary glands (SG) and 3 guts (Gut) of nymphal buffer-injected (mock-treated) or salp20-
siRNA injected (salp20 siRNA) I. scapularis ticks that fed on mice for 5 days.  The RNA 
was subjected to RT-PCR with salp20- and actin-specific primers.   
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Treatment # attached/total number injected 
Mock 15/15 
salp20 dsRNA 13/15 
salp20 siRNAs 0/15 
nonsense siRNAs 0/15 
 
Table 5.2 Numbers of nymphal I. scapularis ticks that attached to mice after dsRNA 
microinjections. 
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Fig 5.2 Antibody responses and specificities from mice immunized with recombinant ILP 
proteins. A. Microtiter plates were coated with S20NS, S20L12, and S20L2 and then 
incubated with immune mouse sera (diluted 1:100) from mice that were immunized and 
boosted subcutaneously with 10 µg of recombinant insect-derived S20NS, S20L12, and 
S20L2 individually (S20NS IMS, S20L12 IMS, S20L2 IMS) or in combination (combo #1 
IMS, combo #2 IMS).  Bound antibodies were detected by ELISA with a secondary AP-
conjugated goat α-mouse IgG. B. Approximately 100 ng of S20NS, S20L12, S20L2, CAT, 
and 25 µl of culture media from stably transfected insect cells expressing S20S were probed 
with immune serum from a mouse immunized with S20NS (1:100) or with a monoclonal 
mouse α-V5 antibody (1:5000) and a secondary HRP-conjugated goat α-mouse IgG.     
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Fig 5.3 Weights of nymphal I. scapularis ticks fed on mice immunized with recombinant ILP 
proteins.  Groups of engorged nymphal I. scapularis ticks that fed on mice immunized with 
S20NS, S20L12, and S20L2 individually (S20NS, S20L12, S20L2) or in combination 
(combo #1, combo#2) were weighed.  Nymphal ticks that fed on mice injected with PBS 
(Mock) were also weighed.  Average tick weights in each group are represented by the 
horizontal line. 
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CHAPTER 6 
 
Discussion 
 
 
 Hematophagus ectoparasitic arthropods, including ticks, are major pest of animals 
and humans, and transmit numerous bacterial, viral, and protozoan pathogens that cause 
devastating diseases.  Arthropod control strategies typically involve the use of insecticides, 
which present many disadvantages including environmental pollution, human health risks, 
and the development of insecticide resistant arthropods.  I. scapularis, the blacklegged tick, 
is an extensively studied arthropod since it transmits a variety of pathogens, including the 
causative agent of Lyme disease.  Elucidating proteins and mechanisms that are important for 
successful blood feeding in I. scapularis will provide further insight into the feeding process 
of the tick, and potentially other blood feeding arthropods. The future characterization of 
proteins and mechanisms important for successful arthropod blood feeding may aid in the 
development of alternative strategies to control arthropods and pathogen transmission.     
 
6.1 Characterization of I. scapularis anti-complement proteins 
 I. scapularis and I. ricinus ticks express a large family of anti-complement proteins, 
the ILP family, that specifically inhibit the alternative complement pathway (2, 3, 23, 26, 28).  
ILPs uniquely interact with properdin, a positive regulator of the C3 convertase, displacing it 
from the convertase, which ultimately leads to decay acceleration of the C3 convertase (2) 
(Chapter 3) (Fig 6.1).  In the future, we plan on further characterizing the interaction between 
 
ILPs and properdin.  Properdin is primarily composed of 6 TSRs flanked by short N- and C-
terminal regions (7, 16).  These TSRs are important for mediating the interaction of 
properdin with Bb, C3b, and the C3 convertase, and for binding surfaces (10, 13, 21).  
Specifically, the TSRs have been shown to interact with sulfated glycoconjugates and 
glycosaminglycans (8, 13).  The possibility exists that the numerous N- and O-linked 
carbohydrates of ILPs mediate their interactions with properdin.  In support of this 
possibility, we were unable to detect a direct interaction between an E. coli expressed 
glutathione S-transferase (GST)-Salp20 fusion protein that lacked post-translational 
modifications (data not shown).  However, the lack of interaction between properdin and 
GST-Salp20 may be the result of the large GST tag, ~ 25 kDa, which possibly prevents the 
appropriate folding and activity of Salp20.  Future studies are aimed at evaluating the 
properdin binding capabilities of insect derived recombinant ILPs lacking N- and O-linked 
glycans that will be generated either through various enzymatic deglycosylations or through 
protein production in the presence of glycosylation inhibitors.      
 
 6.2 Determination of the purpose of ILP family production 
 Couvreur et al. and Daix et al. demonstrated that multiple ILPs are coexpressed 
during tick feeding (2, 3).  Since individual ILPs typically displayed partial inhibition of the 
alternative complement pathway (Chapter 4), we believed multiple ILPs acted synergistically 
when coexpressed during tick feeding, resulting in complete inhibition of the alternative 
pathway.  However, when mixed together, multiple I. scapularis ILPs displayed partial 
inhibition of the alternative complement pathway, similar to activity observed with individual 
ILPs (Chapter 4).  As an alternative possibility justifying ILP coexpression, individual ILPs 
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may potentially display host specificity as both I. scapularis and I. ricinus feed on numerous 
animal hosts.  Yet, we detected no differences in the inhibitory activity of individual I. 
scapularis ILPs when incubated with various host animal serum sources (Chapter 4), 
comparable to the results obtained with I. ricinus ILPs in similar experiments (2, 25).  
Another alternative possibility explaining ILP coexpression is that different ILPs display 
multiple functions besides complement inhibition by potentially interacting with other TSR-
containing proteins in addition to properdin.  In these studies, we demonstrated that different 
ILPs specifically interact with only properdin and not other TSR-containing proteins.  
However, as only two other proteins containing TSRs, ADAMTS-13 and TSP-1, were 
assayed, ILPs may still be capable of displaying multiple functions, unrelated to ADAMTS-
13 and TSP-1, that facilitate blood feeding in hosts.   
 Since ILPs potentially contain numerous N- and O-linked carbohydrate residues, 
these proteins may also be capable of inhibiting the mannose-binding lectin complement 
pathway.  The MBL pathway is initiated when MBL binds high density terminal mannose 
residues on activating surfaces, resulting in the recruitment and activation of MASPs (6, 15, 
24, 30, 31).  The carbohydrate residues present on different ILPs may bind MBL, preventing 
it from recognizing sugars on activating tick surfaces.  We are currently interested in 
determining if different ILPs bind MBL and possibly prevent activation of the MBL 
complement pathway in addition to inhibition of the alternative complement pathway.    
 Couvreur et al. have recently demonstrated that individual I. ricinus ILPs display 
antigenic variation, which potentially explains ILP coexpression during tick feeding (2).  As 
I. ricinus ticks, like I. scapularis ticks, feed on a host for several days, the host has ample 
time to develop to immune responses, including antibody responses, against tick salivary 
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proteins.  Furthermore, I. ricinus and I. scapularis ticks may repeatedly feed on the same 
hosts as the ticks live within the vicinity of their animal hosts.  After an initial exposure to 
tick salivary antigens, the animal host may develop antibodies against the antigens, 
preventing a second successful tick feeding.  In order to circumvent these antibody responses 
and feed successfully without rejection, the tick may produce antigenically variable salivary 
proteins.  Future studies are directed at evaluating the antigenic variability of the different I. 
scapularis ILPs.   
 Besides the possibility that ILPs are antigenically variable, ILPs may also display 
slight variations in their functions.  Even though S20L12, S20L2, and S20NS bind properdin 
with similar affinities, they may bind different domains of the protein.  Within properdin, 
TSR-5 mediates the C3b interaction while TSR-6 facilitates polymerization, resulting in the 
formation of active properdin tetramers, trimers, and dimers (10, 19, 21).  It is possible that 
different ILPs bind different TSRs of properdin, preventing its interaction with C3b or its 
polymerization, both of which would result in functional inactivation.  Determining the 
specific domains of properdin that are bound by different ILPs will provide further insight 
into the functions and purpose of multiple ILP family members.  Regardless of the outcomes 
of our future studies, characterizing differences that exist between ILP family members will 
hopefully elucidate the overall function of the I. scapularis anti-complement protein family 
and other various immunosuppressive tick salivary protein families.  Regardless of the 
outcomes of our future studies, characterizing differences that exist between ILP family 
members will hopefully elucidate the overall function of the I. scapularis anti-complement 
protein family and other various immunosuppressive tick salivary protein families. 
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6.3 Importance of the ILP family during tick feeding and pathogen transmission  
 As I. scapularis produces multiple anti-complement proteins with identical functions 
that are likely coexpressed during tick feeding, the ILPs are probably vitally important for 
successful tick feeding.  Soares et al. have demonstrated that silencing of isac by RNAi 
results in reduced I. scapularis fed nymphal tick weights and inefficient pathogen 
transmission (26).  However, the results of Soares et al. are not definitive as several variables 
that existed in the execution of the experiments, unrelated to the effects of RNAi, may have 
caused the observed reduced tick weights.  Therefore, a thorough evaluation of the necessity 
and importance of the ILP family during tick feeding is still needed.   
 Microinjection of salp20-specific siRNAs, as well as nonspecific siRNAs, into 
nymphal I. scapularis ticks resulted in reduced tick attachment, while the microinjection of 
full-length salp20 dsRNA had no effect on tick feeding.  Additionally, the generation of 
antibodies directed against specific ILPs had no effect on I. scapularis nymphal tick feeding 
(Chapter 5).  These results suggest that the ILP family is potentially not necessary for 
successful nymphal tick feeding.  However, as these experiments were not properly 
optimized, no definitive conclusions should be drawn.  In the future, the optimal 
composition, delivery method, and concentration of salp20-specific siRNAs or full-length 
dsRNAs that effectively silence ILP gene expression during tick feeding need to be 
determined.  Once those variables are established, these RNAi studies in I. scapularis may 
provide more definitive results.  Immunization studies may also be more definitive if mice 
are immunized with more than three recombinant proteins, potentially generating antibodies 
against most, if not all, of the ILP family members.  If we successfully optimize these studies 
and still observe no significant effects on nymphal tick feeding, we should then pursue these 
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studies in I. scapularis adults as currently, effects on tick feeding times and fed tick weights 
by RNAi mediated gene silencing have primarily been observed with adult ticks.   
 In addition to their possible roles for successful tick feeding, ILP family members 
may also be vital for efficient transmission of B. burgdorferi.  Ramamoorthi et al. recently 
demonstrated that RNAi mediated silencing of salp15, and inhibitor of T-cell proliferation 
and IL-2 production, had no effect on successful nymphal tick feeding but prevented the 
efficient transmission of B. burgdorferi to a murine host (22).  Sukumaran et al. also recently 
determined that RNAi mediated silencing of salp16, an I. scapularis salivary protein with 
unknown functions, prevents the successful migration of Anaplasma phagocytophilum, the 
causative agent of human anaplasmosis, from the tick gut to the salivary glands during 
feeding and tick infection (27).  Since S20NS prevented complement-mediated killing of 
serum sensitive B. garnii spirochetes by NHS in vitro (Chapter 2), S20NS, and other ILPs, 
may aid in successful pathogen transmission in vivo by preventing complement activation.  
Future studies are aimed at testing this possibility. 
 
6.4 The I. scapularis genome project and ILPs 
The goal of the I. scapularis Genome Project, a collaborative effort between the 
international community of tick researchers and two genome sequencing centers, is to 
perform whole genome shotgun sequencing of I. scapularis to approximately six-fold 
coverage of the genome (11).  Compared to sequenced fly genomes, I. scapularis has a larger 
genome (2.1 x 103 Mbp), which is uniquely organized into 27% highly repetitive, 39% 
moderately repetitive and 34% unique DNA (29).  Currently, more than 18 million trace 
reads, representing approximately five-fold coverage of the genome, have been deposited at 
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the National Center for Biotechnology Information (NCBI) trace archive (18).  In addition, 
20 Ixodes BAC clones, 370,000 BAC-end reads, and more than 80,000 ESTs have also been 
sequenced.  By mid-2008, sequencing, assembly, and annotation of six-fold coverage of the 
Ixodes genome are expected.  The complete I. scapularis genome will provide valuable 
information about the origination and regulation of different ILP family members and likely 
help with the identification and of other salivary protein gene families. 
 
6.5 Development of an anti-tick vaccine  
 As ticks are continual pests of humans, pets, and livestock, transmit numerous 
pathogens to animals, and cause devastating effects in livestock populations, numerous 
efforts have been employed to control tick feeding and pathogen transmission.  Current tick 
control strategies involve the use of acaricides, but acaricides present multiple disadvantages 
such as food contamination, environmental pollution, human health risks, and the emergence 
of acaricide-resistant ticks (4, 5, 17).  Vaccination strategies directed against specific tick-
transmitted pathogens are somewhat impractical as ticks transmit such a wide variety of 
pathogens.  Therefore, vaccines directed against various tick antigens that potentially prevent 
successful tick feeding and pathogen transmission present an attractive alternative to the 
current tick control strategies.  The feasibility of anti-tick vaccines is supported by the 
development of TickGARD, a vaccine based on the recombinant concealed B. microplus tick 
gut protein, Bm86, which induces strong antibody responses in immunized cattle, resulting in 
reduced survival of feeding B. microplus adults (32).  However, as Bm86 is a concealed 
antigen, repeated immunizations must be administered to induce effective tick blocking 
antibody titers.  Labuda et al. have recently demonstrated that vaccination of mice with a 
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recombinant R. appendiculatus protein identified in the midgut and salivary glands, 64TRP, 
protects mice from tick-borne encephalitis virus infections as well as prevents ticks from 
acquiring the virus from infected mice during feeding, indicating the plausibility of the use of 
tick antigens as pathogen-transmission blocking vaccines (14).   
 Exposed tick salivary antigens are attractive anti-tick vaccine candidates since 
repeated tick feedings on immunized animals would boost the immune responses generated 
by initial immunizations, eliminating the need for repeated immunizations.  Furthermore, the 
generation of immune responses directed against various immunosuppressive tick salivary 
proteins would potentially prevent successful tick feeding and block pathogen transmission.  
The ILP family may be useful in the development of anti-tick and pathogen transmission 
blocking vaccines as members are exposed in the host during feeding.  However, if the 
different ILP family members display antigenic variation, and moreover, if members of other 
immunosuppressive tick salivary protein families also display antigenic variation, the 
development of a multivalent anti-tick vaccine directed against numerous exposed salivary 
antigens will be necessary.   
     
6.6 Use of ILPs as therapeutic agents in complement mediated diseases 
 Inappropriate activation or uncontrolled regulation of the complement cascades leads 
to the development of numerous inflammatory and autoimmune diseases (24).  Multiple 
groups have demonstrated with the use of fB and fD deficient mice that the alternative 
complement pathway is involved in the development of several diseases including 
rheumatoid arthritis, lupus nephritis, ischemia-reperfusion injury, anti-phospholipid 
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syndrome, experimental allergic encephalomyelitis, and pulmonary disease (12).  Currently, 
numerous efforts are directed at developing effective complement-specific therapies.   
 The ILPs are potentially appealing complement-specific therapeutics as they are small 
proteins that are likely to be stable in vivo since they are naturally secreted into hosts by 
ticks.  Furthermore, since the ILPs specifically inhibit the alternative complement pathway 
by binding properdin, the classical and MBL pathways would still be functional in ILP 
treated individuals, which would provide partial complement-mediated immunity against 
invading microorganisms.  The use of tick proteins as therapeutics seems very feasible as 
Paveglio et al. have recently established that I. scapularis Salp15 prevents the development 
of experimental murine asthma (20).  In addition, Hepburn et al. demonstrated that O. 
moubata OmCI, an inhibitor of the complement pathway that directly binds C5, prevents the 
development of the experimental autoimmune myasthenia gravis, a neuromuscular disorder, 
in rats (9).  We are currently investigating the potential of S20NS as a therapeutic agent that 
inhibits the development of alternative pathway complement-mediated diseases in vivo.   
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Fig 6.1 Proposed model of ILP (S20NS) complement inhibitory activity.  The C3 convertase 
(C3bBb) is stabilized by properdin, which binds the convertase and significantly increases its 
half-life.  During tick feeding, ILP proteins (S20NS) secreted into the host in tick saliva 
directly interact with properdin, removing it from the C3 convertase.  Once properdin is 
removed, the C3 convertase rapidly decays and surface bound exposed C3b is available for fI 
mediated degradation.  Figure adapted from (1). 
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